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ABBREVIATIONS
I.F. - Intrinsic Factor
B^2 - Vitamin where the form is not
being specified.
57[ Co] cyanocobalamin - cyanocobalamin radioactively labelled
57
with; the isotope Cobalt.
1 9R
[ I] I.F. “ intrinsic factor labelled with the
125
isotope Iodine
I.F.-8^2 - the complex of vitamin B^2 bound to
intrinsic factor.
57I.F.-[ Co] cyanocobalamin - the complex of cyanocobalamin labelled
57
with [ Co] bound to intrinsic factor • 
Ab - Antibody
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SUMMARY
The main aim of this research work was to isolate pure 
preparations of both human and hog Intrinsic Factor and examine 
some of their physico-chemical and immunological properties.
The method chosen to isolate pure I.F. was affinity 
chromatography, in particular the method used by Allen and 
co-workers in America. Their method was studied and modified, 
mainly by the use of lower molarity guanidine-HCl to elute the 
affinity chromatography column, thus providing a method of 
separating I.F. from non-I.F, binders.
The results gained in the present work by amino acid analysis 
and gel filtration were similar to those gained by Allen except 
that the carbohydrate composition of the hog I.F. did not contain 
any galactosomine and there was no appearance of any dimerised or 
oligomerised form of I.F. The molecular weight for both human
and hog I.F. was approximately 60,000 and the other physico-chemical 
properties were similar for both preparations.
The two were not identical immunologically, since the Type II 
antibody, which was raised to human I.F, would not react with hog I.F
Both human and hog I.F. preparations were successfully labelled 
125
with [ I] using the Chloramine T method and this preparation was 
used to compare the properties of I.F. with and without the addition 
of 8^2 .
- 17
Methods for possible elucidation of I.F. mediated 
absorption from the intestine are suggested using a peroxidase 
linked to specific I.F. antibody staining technique and also a 
specific radioimmunoassay for very small quantities of I.F.
A routine clinical radioassay for B^^ is also described.
- 18 -
INTRODUCTION
The initial project undertaken during the course of study was 
an examination of methods of measuring vitamin in
biological material by radioassay.
Measurements of B^^ for clinical use by microbiological assay 
were introduced by Ross in 1952 (1) and have proved to be of value 
in clinical and academic practice. In 1961, Barakat and Ekins 
introduced a radioassay (2) which appeared to have some assets over 
microbiological techniques especially in the shorter amount of 
time required. Although over ten years had elapsed since this 
first description of a radioassay method, it is clear from the 
multiplicity of techniques which have emerged and from the comparative 
studies of radioassay and microbiological results (3 - 15) that no 
single-method has gained uniform acceptance. The general principles 
of all radioassay methods for estimating B^^ .^re essentially the
same
1. Extraction of B^^ the test sample from its 
binding proteins.
2. Addition of a substance with a finite, reproducable 
B^2 binding capacity for use in the competition 
between the added hot and endogenous cold
3. Separation of free from bound 6^2 »
- 19 -
From a study of the various methods employed in radioassay 
work it was obvious that the choice of a binder was a central 
issue. With this in mind, a project was initiated to look at 
possible B^2 binders and develop a reliable radioimmuno-assay for 
6^2 " The possible sources of binder studied were commercial hog 
intrinsic factor (I.F.), human serum, rabbit serum, chicken serum 
and charcoal granules encapsulated in dialysis membrane. It was 
found that chick serum contained a great deal of B^2 binding protein 
and an assay system was developed using dilute chick serum with 
albumin coated charcoal for separation of free and bound This
assay was being compared to the existing microbiological assay in 
use in the Southern General Hospital, Glasgow and a commercial 
radioassay kit when a paper was published (9) describing an essentially 
similar assay. At much the same time a series of papers appeared 
on the isolation of B^2 binders by the relatively new technique of 
affinity chromatography by Allen and co-workers in America (16-20) . 
These papers appeared to provide a relatively simple method of 
obtaining a pure B^2 binder.
It was therefore, decided to abandon further study of the 
radioassay and to concentrate on the isolation of pure B ^^ 2 binders.
While this alteration of course limited, to a certain extent, 
the amount of time available for study, it was felt that work on 
the isolation of pure B^2 binders would be of value not only to 
confirm the original work of Allen, but also to examine the properties 
of pure vitamin B ^^ 2 binders in vivo and in vitro with a view to
20
resolving conflicting results found by other workers using impure 
or partially purified preparations.
The term 'binder* is used in the literature on to denote 
substances which complex with B^2 * The specific binders of B^^ 
can be divided into two groups, the so called R-binders (the R 
being derived from the more Rapid electrophoretic mobility of 
these materials) which do not appear to have a clearly defined 
biological function and the specific binders whose role has been 
discovered. One of the specific binders has the somewhat intriguing 
name of "Intrinsic Factor" (I.F.) which has a role in the absorption 
of B^2 the intestine and the others are classified as the 
Transcobalamins [TCI, TCII, § TCIII] which have a role in the 
intravascular transport of B^^ (21).
The transcobalamins are present in blood in such very small 
quantities that it was not possible to obtain sufficient serum to 
make their isolation in sufficient quantity to study their properties 
a practical possibility. It was, therefore, decided to concentrate 
our effort in isolating I.F. from human gastric juice and from 
commercial freeze-dried dessicated hog gastric mucosa.
The existance of I.F. was postulated by Castle in 1928 (22).
He and several others had observed that beef muscle fed to patients 
with pernicious anaemia did not induce haematological response unless 
it was preincubated with normal human gastric juice or given along 
with normal human gastric juice. The term "intrinsic factor" was
- 21
used for the substance in normal human gastric juice which, Castle 
postulated, combined with an "extrinsic factor" in beef muscle to 
form a "haemopoetic factor" which was absorbed and alleviated the 
disease.
Wlien was isolated in 1948, almost simultaneously by Lester 
Smith with Glaxo (23) in Britain and Folkers with Merck (24) in 
America, it was recognised that B^^ exhibited the properties of 
"extrinsic factor". It was observed, however, that B^^ given 
parenterally could induce a haematological remission in pernicious 
anaemia. This fact, together with the demonstration that radio­
active cyanocobalamin could not be absorbed by patients with pernicious 
anaemia except when given with a source of I.F. led to the modification 
of Castle's theory that the function of I.F. was to mediate the 
absorption of B^^- Vitamin B^^ appears to be the only dietary 
requirement among animals which is solely produced by microorganism 
e.g. streptomyces griseus, which may explain why a unique mechanism 
has evolved for its absorption requiring I.F,
Work on the isolation of I.F. and its structure has proceeded 
only slowly for a variety of reasons. Initially the only method 
of measuring I.F. activity was by biological effect as judged by 
a reticylocyte count in patients with pernicious anaemia in relapse 
and it was not until 1965 that Gottlieb et al (25) introduced a 
type of radio assay method for the detection and quantification of 
I.F.
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While certain properties of I.F., notably its thermal lability, 
had been observed by Castle (26, 27), the progress in the character­
isation and isolation of I.F. was disappointingly slow for many 
years, this being largely related to the technical methods available
In 1952, Glass and his group isolated a glycoprotein fraction 
from human gastric juice (28) which exhibited the properties of 
I.F. but required daily dosage of 100 mg of their fraction plus 
20 |Jig to produce a haematopoeitic response. With the advent 
of techniques such as continuous electrophoresis, ion exchange 
chromatography, gel filtration, sequential ammonium sulphate 
precipitation and ultra-centrifugation, progress became more rapid. 
However, most of the purification procedures described are tedious 
and contain many stages e.g. the seven-stage purification achieved 
by Grasbeck et al in 1966 (29) used a starting pool of 40 litres 
of gastric juice from 276 patients but only recovered about 20% 
of the original I.F. activity, and some of this [complex 1] was 
thought to be partly degraded.
This and the other work was reviewed by Glass in 1963 in his 
substantial monograph (30) which contained over 1400 references.
This review was updated in 1974 in a volume which gives a further 
700 references (31), thus giving some indication of the volume of 
work done on this substance.
Until recently, probably the most pure preparations isolated, 
apart from Grasbeck's, would be those of Chosy and Schilling (32)
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using ion exchange chromatography, gel filtration and ultrafiltration 
on human gastric juice and Ellenbogen and Highley (33) on hog pyloric 
mucosa. They used a multi-step procedure which included ammonium 
sulphate precipitation ion exchange chromatography, proteolytic 
digestion of the products and further column chromatography. Both 
these preparations were biologically active at doses of less than
0. 5m g.
In 1970, Grasbeck and co-workers suggested that analogues 
could be co-valently bound to cellulose to yield an adsorbent for 
B^2~binding proteins (34) and in 1971 a paper was published by Olesen 
et al (35) in which described a method for coupling a hydroxocobalamin- 
albumin conjugate to bromoacetyl cellulose.
What appeared to be a dramatic advance came in 1972 with the 
publications of Allen et al (16 - 18) describing the isolation of
1.E. by another modification of this technique of Affinity 
Chromatography, This group used the monocarboxylic derivative of 
cyanocobalamin bound to 3, 3' diamino-dipropylamlne substituted 
Sepharose-4B via a 1-ethyl 3-(3 dimethylaminopropyl)-carbodiimide 
bridge as their affinity adsorbent. The vitamin B^2 binding 
proteins were eluted from the column by partially denaturating
them with 7.5M guanidine-HCl and then renaturating them by dialysing 
off the guanidine against water.
The particular attractions of this technique are that it has 
relatively few steps and the yields of apparently pure I.E. are 
higher than with previous methods.
- 24 -
In essence, the major part of this thesis is a report of a 
study of the isolation of human and hog intrinsic factor using 
the above method of affinity chromatography. Also the pure 
proteins isolated have been studied with a view to characterising 
some of their physical, chemical and immunological properties. 
This work is, by necessity, of a preliminary nature, but some 
possible uses of pure I.F. have been explored and it is hoped 
will form a basis for further work.
- 25 -
CHAPTER I
RADIO-ASSAY FOR VITAMIN
- 26 -
INTRODUCTION
The assay described here is a simplified, reproducible and 
economic isotope dilution assay for quantification in biological 
material arrived after testing various methods of releasing B^2 
from its natural binding proteins, possible B^^ binders for use in 
the competition between labelled and unlabelled B^^ .^nd methods 
of separating free from bound
The final assay developed is described here because a substantial 
amount of time at the beginning of the research period was expended 
on it and also because it was used during subsequent research as 
a method for determining B^^ levels in various preparations. However, 
since this assay is not being presented as the major outcome of 
the research, the results of the work on possible methods and materials 
for the assay, which were later discarded as less suitable than those 
employed finally, are not presented here.
Chick serum was finally chosen as the binder in this assay 
because of certain properties it was found to possess. It had a 
very high unbound binding capacity for B^^ which meant it could be 
used highly diluted. Its binding capacity was linear over the 
range of physiological B^^ values and was more stable than other 
binders to environment, e.g. pH, ionic strength, presence of extraneous
- 27 -
material and storage conditions. Chick serum binding has been 
found to be associated with a single binder (36) which may account 
for the linearity of its binding properties. Comparison of chick 
serum to some other B^2"binding agents has also been described by 
Newmark et al in 1973 (8).
MATERIALS AND METHODS
57
High specific activity [ Co] cyanocobalamin (approx. 150 yCi/pg) 
supplied from Radiochemical Centre, Amersham, was diluted with a 
solution of unlabelled crystalline cyanocobalamin (Glaxo Ltd.) in 
0.2M acetate-cyanide buffer pH 4.3 to a concentration of 1 ng/ml.
The specific activity was adjusted so that 50 jil of this solution 
gave approximately 10,000 c.p.m.
Acetate-cyanide buffer was prepared from 700 ml of 0.2M acetic 
acid, 300 ml of 0.2M sodium acetate, 50 mg potassium cyanide and 
29.2g Sodium Chloride. The same buffer was used both for extraction 
and assay, and it proved to be stable for at least two weeks at 4°C.
Cyanocobalamin standards were prepared from crystalline 
cyanocobalamin (Glaxo Ltd.) diluted in the dark in acetate cyanide 
buffer to 1600 pg/ml.
Pooled chick serum was supplied from the Immunology Department 
Western Infirmary Glasgow. It was diluted 1 in 350 in 0.15M saline 
solution and frozen in 1 ml aliquots at ~20°C, under which conditions
- 28
it was stable for at least 6 months.
The albumin coated charcoal used was a suspension of neutralised 
Norit I activated charcoal (Sigma Chemical Company) in Bovine serum 
albumin fraction V solution from B.D.H. Ltd. Normally Ig charcoal 
and 0.2g albumin were mixed together in 40ml distilled water and 
allowed to incubate at room temperature for at least 30 minutes 
before use. This suspension was stable for up to 1 week at 4°C,
PREPARATION_OF_TEST_SAMPLE
0.5ml of the unknown test sample was added to 2.5ml acetate- 
cyanide buffer in a 15cm x 1.5cm pyrex glass test tube fitted with 
a metal cap. The mixture was boiled for 20 minutes in a water 
bath at 100“C, It was then shaken to facilitate protein separation 
and cooled to approximately 25°C quickly in running tap water.
The tube was then centrifuged at 3000g for 15 minutes to separate 
the denatured protein, and 2 x 1ml samples of the clear supernatant 
removed into duplicate 10cm x 1.5cm glass test tubes.
PREPARATION OF STANDARD CURVE
A serial dilution of the previously prepared 1600 pg/ml 
unlabelled cyanocobalamin was set up using acetate-cyanide buffer
29
to give seven tubes containing respectively 0.5ml of the concentrations 
1600, 800, 400, 200, 100, 50 and 0 pg/ml cyanocobalamin, the last 
tube containing only 0.5ml acetate cyanide buffer. To each of 
these tubes was added 2.5ml buffer, they were shaken and 2 x 1ml 
aliquots from each were transferred into duplicate glass tubes 
labelled 1600 - 0. These tubes were then treated in the same way 
as the unknown test samples.
ASSAY PROCEDURE 
5750p,l of [ Co] cyanocobalamin solution previously prepared 
was added to each of the unknown sample tubes and to the standard 
curve tubes and mixed. This volume contained 50 pg labelled 
cyanocobalamin which was the amount found to give the most sensitive 
results. A suitable quantity of the diluted chick serum was allowed 
to defreeze at room temperature and 50 jil of this solution was 
added to each tube. Two background control tubes were also set 
up, which did not receive any chick binder. The tubes were 
incubated at room temperature for 15 minutes before adding 1 ml 
of the charcoal suspension to each tube, mixing and incubating for 
a further 10 minutes. The tubes were then centrifuged at 3000g 
for 10 minutes and 1 ml of the clear supernatant removed from each 
tube into a clean labelled glass test tube and counted for radio­
activity in a well type gamma scintillation counter using a J § P 
Engineering MS310 Counter/Ratemeter. This separation of free from
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GRAPH I - Typical standard curveof Free/Bound ratio of [ Co] 
against a serial dilution of competing unlabelled cyanocobalamin 
using Chick Serum as binding agent.
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Free/Bound ratio40
of Co cyanocobalamin35
25
20
concentration of (pg/ml)
0
50 100 200 400 800 1600
(b) Unknown Samples
The counts in 1 ml of the supernatants of the unknown samples 
were treated in the same way and by application of the Free/Bound 
ratio calculated for each sample to the standard curve, a direct 
reading of the concentration of the sample in pg/ml was
found. Any sample with too high a concentration for this range 
was suitably diluted in acetate cyanide buffer and assayed again.
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COMPARISON OF CHICK SERUM ASSAY_WITH_MICROBIOLOGICAL_ASSAY_MD_WITH 
CQMMERCIALLY_AVAJLABLE_RADIO-ASSA^_KIT.
A number of patient sera, covering the range of physiological 
B^2 values were obtained from the Haematology Department, Southern 
General Hospital, Glasgow, where a sample from them had already 
been subjected to a microbiological assay using Lactobacillus 
Leichmannii (37, 38) and a result obtained. Such sera were 
assayed at various stages of the development of the present assay, 
as a check on the comparability of results from the two methods. 
When the assay was in its final form, as described above, it was 
used to assay a number of sera which were also assayed by the 
microbiological technique. The results from the chick serum 
radioassay were not previously known to the people carrying out 
the microbiological assay and vice versa.
The correlation in a range of 25 samples assayed by both 
methods as shown in Fig. 1 was very good.
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FIG. I - Correlation between the results_of_serum levels 
obtained by both radioisotope dilution assay using chick serum 
as binder and microbiological assay using Lactobacillus Leichmannii
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= [45°] line of identity
1600r
ho
1400-“
•H
lOOO-
800-"
•H
600 ■’
pH
CN
20CT*CO
1200 1400 1600400 600 800 1000100 200
Serum B^^ level using Lactobacillus Leichmannii (pg/ml]
The calculated regression line for the two methods has the 
formula y - 0.9627x + 18.3 with an r value of 0.9506 (p <* 0.01).
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This means, as is also shown in Fig. 1, that the calculated 
regression line is very close to the [45°] line of identity, thus 
the normal range of results for both methods is effectively identical 
(150 - 1400 pg). No untreated Pernicious Anaemia patient tested 
with chick serum radioassay had a level higher than 130 pg/ml 
and most were considerably lower.
In all, over 100 sera were tested using this chick serum radio­
assay. The diagnoses for these patients included - pernicious 
anaemia, folate deficiency, abnormal intestinal absorption, post 
gastrectomy, diabetic, treated pernicious anaemia. Serum was also 
tested from healthy volunteers.
Some of the sera were also tested with the Phadebas Test 
Kit supplied by Pharmacia. The calculated regression line for 
the correlation between these results and the Chick serum radio­
assay had the formula y = 0.9806x + 102, with an r value of 0.9739 
(p 0.01). Thus the kit gave a very good correlation with the 
developed assay but with a higher normal range of values, i.e. above 
250 pg B^g/ml serum.
KEPRODUCABILITY_OF_CHICK_SERUN^RADIOAGSAY
Samples from the same serum pool were assayed each time an 
assay was being performed over a period of time. When 20 results
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had been obtained they were analysed statistically and found to
have a mean value of 257 pg/ml and a standard deviation of - 14.7pg/ml.
This is a coefficient of variance of 5.7 (p <  0.05).
Also from the values found for duplicate samples for over 
150 assays the correlation coefficient was found to be 0.9975 (p<0.01)
DISCUSSION
Although in samples which were assayed with and without the 
centrifugation step to remove denatured protein, there was not found 
to be any significant difference (p<ro.05), it was decided to 
include the step because it allowed the withdrawal of 2 x 1 ml 
duplicate samples of clear supernatant ..which more closely 
resembled the media of the standard curve tubes. It was also 
felt that it reduced the risk of any spontaneous partial renaturation 
of any peptide strands which might have some non-specific B^^^'binding 
activity (39). This risk was also lessened by cooling the denatured 
serum quickly down from 100°C.to room temperature using cold running 
tap water.
Although chick serum does not exhibit its highest possible 
binding capacity at pH 4.3, this pH was chosen for the following 
reasons. The assay was substantially simplified, since extraction 
and assay and standard curve were all carried out in the same buffer. 
This buffer had sufficient buffering capacity to maintain its pH
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during extraction.
Also it was found that at higher pH levels, the results gained 
from the assay were consistently higher than those gained from the 
same sample using the .microbiological assay. Whereas at pH 4.3 
the results were very similar. In the past, most radio-isotope 
dilution assays have tended to give higher results than micro­
biological assays (9, 10, 11, 15) and this may be one reason why, 
although radioassays are much faster to carry out than microbiological 
assay, they still have failed to be generally used clinically. This 
may be due to people being unwilling to adjust to a new range of 
normal and abnormal values.
Thus it was decided to adjust the assay conditions to yield 
results which were in the same range as the microbiological results 
as far as possible.
The ionic strength chosen (0.5M) was sufficiently high to 
minimalise any possible differences between the standard curve 
samples and the test samples. It was found that results were 
more reproduceable when cyanide was added to the buffer (13).
The radioassay was much more sensitive than the microbiological 
assay, and in assays carried out with known concentrations of 
cyanocobalamin it could distinguish 10 pg/ml differences in 
concentrations and could also be used at concentrations below 50 pg 
cyanocobalamin/ml,
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Although only a few sera were assayed using the Phadebas 
Kit, it was found to give satisfactory results which were 
comparable to those found by Raven § Robson (11) and Frenkel et 
al (12) with the same kit. However, the binder used in this 
assay, which is an impure I.F. preparation bound to Sephadex (40,41) 
was found to be very delicate and could easily be destroyed e.g. 
by overvigorous mixing. The standard curve obtained for this 
assay was not linear, which was perhaps a function of the non­
homogeneity of the binder, and the treatment of results was more 
complicated.
Also this assay suffered, to a certain extent, from the flaw 
of other radioassays mentioned above, in that the range of results 
gained was higher than that generally accepted, gained from 
microbiological assays.
It was also calculated that if both the chick serum radioassay 
and the commercial radioassay were in general use in a clinical 
situation, it would cost approximately 200 times more to assay one 
sample by using the commercial kit.
Finally, sufficient assays on sera from patients with any one 
specific category of illness were not performed. Therefore, it 
was not possible to ascertain whether this assay gave anomalous 
results with any specific group.
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CHAPTER II
THE ISOLATION OF HOG AND HUMAN INTRINSIC FACTOR USING
AFFINITY CHROMATOGRAPHY
39
INTRODUCTION
The technique of affinity chromatography for proteins depends 
on the unique properties of a given protein to bind specifically 
to given ligands and for this binding to be reversible under 
different conditions. The method requires that the ligand can be 
covalently bound to some insoluble matrix over which the biological 
fluid which contains the protein of interest can be passed. This 
protein should bind to the "affinity adsorbent" while all the other 
miscellaneous biological material can be washed through. Then, 
when only the protein of interest is left behind, the physico-chemical 
conditions are changed in such a way as to cause the release of this 
protein from its ligand and thus it can be collected in a pure form.
The technique is very appealing for its apparent simplicity 
and its use of the inherent biological properties of a given material 
to secure its own purification without subjecting it to many 
mechanical separation procedures.
Much of the pioneer work on affinity chromatography for proteins 
was done by Cuatrecasas and his co-workers (42) in the late 1960's.
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He recognised that cross-linked dextran (Sephadex) exhibited 
properties which would make it an efficient insoluble matrix on to 
which the biological ligand could be bound i.e. it was stable 
mechanically and chemically, had good flow properties, was free 
from non-specific adsorption effects with proteins and formed gel 
particles of uniform spherical size. He also saw that for maximum 
biological interaction between ligand and substrate, the ligand must 
be far enough away from the support backbone to prevent steric 
hindrance.
Thus he developed several methods for either attaching a long 
hydrocarbon chain or "bridge" to the ligand before attachment to 
the insoluble matrix or else attaching the "bridge" to the matrix 
before bonding to the ligand.
In the case of I.F., the ligand which has to be bound to 
the insoluble matrix is cyanocobalamin, or in fact a monocarboxylic 
acid derivative of cyanocobalamin. It is bound via a 3, 3’ diamino- 
dipropylamine bridge to cyanogen bromide activated Sepharose 4B by 
an amide bond formed in the presence of a carbodiimide, according 
to the method of Allen et al (16). This method of preparing the 
affinity adsorbent was followed almost exactly except Spermidine 
was substituted as the bridging chain when 3, 3' diamino-dipropylamine 
was not available and commercially prepared cyanogen bromide activated 
Sepharose 4B (Pharmacia) was used so as to allow the emission of 
the activation step. The exact product of this activation is not 
known but it has been hypothesised (43, 44) that the cyanogen bromide
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reacts with the hydroxyl groups of Sepharose to form cyclic and 
acyclic imidocarbonates which are then available to react with the 
amino groups of the ligand or bridging chain covalently.
In the method used here the 3, 3* diamino-dipropylamine is 
first attached to the CNBr-activated Sepharose and then the mone- 
carboxylic acid derivative of cyanocobalamin is joined to the 
bridging chains, The reaction pathway for the amide bond formation 
is shown in Fig. 2.
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FIG. 2 - Brief Pathway of amide bond formation between mono­
carboxylic acid cyanocobalamin and the 3, 3 ’ diaminodigropyiamine 
substituted Sepharose.
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MECHANISM
The initial step in the formation of the amide bond between 
the monobasic cyanocobalamin and the bridging chain bound to the 
Sepharose is the protonation of the l-ethyl-3-(3 dimethyiamino- 
propyl) carbodiimide-HCl [1] to yield [2]. This intermediate 
product is attacked by the cyanocobalamin monocarboxylic anion to 
produce the 0-acylurea [3] which then rearranges intramolecularly 
to form the N-acylurea [4], [3] and [4] react with the terminal
amino group of the 3, 3 ‘-diamino-dipropylamine chain attached to 
the Sepharose to form an amide bond with the substituted Sepharose 
[5] plus urea. [3] can then react with another cyanocobalamin 
monocarboxylic anion to yield urea plus the acid anlydride [6] 
which can then react with more terminal amino groups of the 
bridging chain to form more amide bonds and thus the cyanocobalamin 
is covalently bound, via the hydrocarbon bridge, to the inert 
support matrix.
In effect, after the hydrolysis forming the amide bond, native 
cyanocobalamin was formed covalently linked through an eight carbon 
chain to the activated Sepharose.
In the isolation of I.F. using this affinity adsorbent, there 
were some modifications made to Allen’s method. These will be 
discussed later.
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The major disadvantage of using affinity chromatography to 
isolate I.F. is that the biological fluids which contain I.F. also 
contain B^2-hinding proteins which do not exhibit I.F. activity, 
(non-I.F. or R-binding proteins). In the isolation of human I.F. 
from gastric juice, particular care was taken to select for 
processing only samples which had >85% I.F. activity in their B^2 
binding. However, since commercial freeze dried hog gastric 
mucosa, which was the source of hog I.F. , contained >60% non-I.F 
binders, some other means of separating I.F. from non-I.F. binders 
was necessary. Again there was introduced a modification to the 
Allen technique, which in fact proved to be a simplification.
This too, will be discussed later.
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SECTION I PREPARATION OF AFFINITY LIGAND AND ISOLATION OF
HUMAN AND HOG I.F.
MATERIALS AND METHODS
Crystalline Cyanocobalamin was obtained from Glaxo Limited
Cyanogen-Bromide activated Sepharose 4B " Pharmacia Limited
Uppsala, Sweden
Q.A.E. Sephadex A-25 ” " " "
Sephadex GlOO " " " "
Sephadex G200 " " " "
3, 3' Diaminodipropylamine " Eastman-Kodak Ltd.
Rochester, New York
l-Ethyl-3-(3 dimethylaminopropyl)carbodiimide
- HCl
■57,
[ Co] vitamin B^^ (specific activity 
approx. 150 uCi/ug)
from Phase Separations Ltd
" Radiochemical Centre, 
Amersham.
Biorex AGI - X8 (acetate form)
Guanidine Hydrochloride - Ultra Pure
" Biorad Ltd.
" Mann Research Laboratories 
Orangeburg, New York.,
" B.D.H. Ltd. and
" Serva, Heidelberg.
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Human Gastric Juice was obtained from Gastro-Intestinal Centre,
Southern General Hospital, 
Glasgow.
Surgical Unit 
Glasgow Royal Infirmary
Western General Hospital, 
Edinburgh,
University Dept, of Surgery, 
Royal Infirmary, Manchester.
University Dept, of Surgery 
Sheffield.
Bovine Serum Albumin, Fraction V 
All materials for buffers
from B.D.H. Ltd,
Activated Neutralised Charcoal " Sigma Chemical Company 
St. Louis
Freeze dried Hog Intrinsic Factor
concentrate Batches WC2650 § TC2750 " Armour Pharmaceuticals Ltd
Folin and Ciocalteus Phenol reagent from B.D.H. Ltd.
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MEASUREMENT_OF_RAUIOAfTIVITY
Unless otherwise stated, activities were measured in a 
well-type scintillation counter I.D.L Type 663 with a thallium 
activated sodium iodide crystal 5.5 cm diameter and 6.9 cm deep 
shielded by 10 cm lead.
The crystal was connected to a J § P Engineering MS 310 
Counter/Ratemeter.
MEASUREMENT OF pH
The pH level of buffers etc. was measured using an E.I.L 
Model 23A direct reading pH meter with a glass electrode.
MEASUREMENT 0F_T0TA1_PR0TEIN_C0NCENTRATI0NS
All total protein concentrations were done by a modification 
of the Lowry method (45) using Folin and Ciocalteus phenol reagent 
and reading the absorbance of the samples at 540nm against a blank 
on a Unicam SP600 spectrophotometer, A standard curve was set up 
using bovine serum albumin.
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PREPARATION_OF M0N0CAKB0XYLIC_AGID_DERIVATIVEJ3F_CYAN0C0BA1AMIN
57
Five grams of crystalline cyanocobalamin and 1 ^Ci [ Co],
0.0067 jjig vitamin B^^ were added to 500 mis of 0.4N HCl and stirred 
at room temperature in the dark for approximately 3 days, to remove 
ammonia from the propionamide side chains on the corrin ring and 
yield the various mono-, di- and tribasic acid derivatives.
The products of this mild acid hydrolysis were applied to a 
column (60cm x 2.5cm) of Bio-Re x AGl-x8 (acetate form) 100-200 
mesh, which had been previously washed with 2 litres of O.IM Sodium 
Acetate followed by 4 litres of distilled water. The column was 
eluted with 0.025M acetic acid and collection of eluant commenced 
when the red material reached the bottom. The bulk of the red 
material was recovered in a volume of 800 mis and this proved to 
contain 95% of the added hydrolysate, as judged by radioactivity.
A sample of the eluant failed to cause any precipitation of silver 
nitrate, showing that all free chloride ions had been removed.
The eluant was then taken to dryness in a rotary evaporator at 60*C, 
redissolved in 300 mis distilled water and the operation repeated. 
Finally the red material was redissolved again in 300 mis distilled 
water and 50 mis pyridine added. The pH of the. solution was 
adjusted to 9 with concentrated NH^ OH and then subjected to ion 
exchange chromatography on a column (60 cm x 2.5 cm) of QAE- 
Sephadex A-25 (chloride form), previously washed with 2 litres 
of 0.2M pyridine, at room temperature. The hydrolysate was applied 
to the top of the column and washed in with 600 mis of 0.4M pyridine,
- 49 —
The column was then eluted with a linear acetate gradient at a 
flow rate of 50 mis per hour, the mixing chamber containing 1 litre 
of 0.4M pyridine, and the reservoir 1 litre of 0.4M pyridine plus 
0.32M acetic acid. The column was further eluted with 1 litre 
of 0.4M pyridine plus 0.32M acetic acid.
The elution could be followed visually since the red material 
separated into well defined bands. Each major band was collected 
separately and evaporated to dryness in a rotary evaporator at 40*C. 
Each was redissolved twice in 100 mis distilled water and re-evaporated 
at 50°C and 60°C consecutively. Each was finally redissolved in 
as small a volume of distilled water as possible (a few ml.), 
transferred to small beakers of known weight, and evaporated to 
dryness in a dessicator under vacuum at room temperature.
Ascending paper chromatography of each of the products was 
carried out on Whatman 3mm Chromatography paper using N-Butyl 
alcohol + Propan-2-ol Water, 2 : 2 : 1  and 0.04% w/v Potassium 
Cyanide, as solvent. It was allowed to run in the dark for 24 
hours at room temperature then dried. Crystalline cyanocobalamin 
and crystalline monocarboxylic acid derivative obtained from Glaxo 
Ltd. were used as standards. The monocarboxylic (100 mg) was 
a gift from Dr. Bilkus, Glaxo Research Laboratories,
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PREPARATION OF THE AFFINITY_ADSORBENT
Ten grams of Cn-Br activated Sepharose-4B were swollen and 
washed in 1 litre 0.0IM HCl, pH 2-3. The Sepharose was then washed 
in a Buchner sinta-glass funnel with 1 litre O.IM Na HCO^, pH-10 
under vacuum at room temperature, transferred to a flask, allowed 
to settle and the excess supernatant removed. Thirty ml. of 2M 
3, 3' diaminpdipropylamine - HCl, pH 10 were added to the flask and 
the mixture stirred continuously with a paddle stirrer for 18 hours 
at room temperature. The substituted Sepharose was poured back 
into a Blichner funnel and washed successively under vacuum with 
200 ml distilled water, 500 ml 0.025M glycine - NaOH, pH-10 
containing O.IM NaCl and 2 litres of water.' After this the 
Sepharose was re-transferred to a flask, allowed to settle and 
the supernatant removed. To this was added O.Sg of Mono-carboxylic 
acid derivative of vitamin B^^ dissolved in 35 mis distilled water 
and the pH raised to 5.6 with 0.2M NaOH. The mixture was gently
stirred continuously with a paddle stirrer and 150 mg l-ethyl-3- 
(3 diethylaminopropyl) carbodiimide dissolved in 3 ml water added 
slowly in 0,5 ml aliquots. After stirring continuously at room 
temperature in the dark for a further 18 hours, the affinity 
adsorbent was finally re-transferred to a Buchner funnel and washed 
successively with 300 ml water, 600 ml O.IM Glycine-NaOH pH-10 
(thus blocking off any bridging chains not filled with vitamin B^g)» 
300 ml water and 300 ml O.IM phosphate buffer pH-7.5. An average 
of 10% of the monocarboxylic acid B^^ added to the Sepharose becomes
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incorporated, giving it a red colour. This amount of affinity 
adsorbent was enough to pour two columns and each column could be 
used approximately six times. The adsorbent could be stored in 
O.IM phosphate buffer pH 7.5 at 4°C (foiled to keep out any light) 
for several months with only slight release of vitamin 
Sodium azide 0.02% w/v was used during storage to prevent bacterial 
growth.
PREPARATION _ OF _ALBUMIN _COATED ^ CHARCOAL
One gram of neutralised activated charcoal was mixed with 
0.2g Bovine serum albumin fraction V and 40 ml distilled water in 
a flask. The suspension was mixed with a magnetic stirring bar 
slowly at room temperature for at least 30 minutes before use, and 
could be stored at 4°C for up to 7 days without impairment of 
function. After this time it deteriorated and could absorb protein
bound B^2 well as free rendering it useless as a separation
technique for these two. While being pipetted out during use, the 
suspension was continuously stirred.
ASSAY OF INTRINSIC FACTOR - IN VITRO
The "in vitro" assay of I.F. binding activity of any sample 
was done using albumin coated charcoal to separate free from bound 
vitamin A duplicate series of glass test tubes was set up
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at room temperature and numbered as shown in Table I. This method 
was a modification of the technique of Gottlieb et al (25)
TABLE I " Protocol for "in vitro" assay of I.F. activity
Tube
Number
Unknown
Test
Material
(ml)
Human
I.F.Ab
Serum
(ml)
O.IM 
phosphate 
buffer 
pH 7.5
(ml)
C^^Co]
vit.B12
7.5 ng/ml
(ml)
Albumin
coated
Charcoal
(ml)
Total Binding 
Capacity of 
Unknown 1 § 1 ' 0.1 0.1 1.0 0.8
Binding 
Capacity 
of Ab.Serum 2 S 2 ' 0.1 0.1 1.0 0.8
Non I.F Binding 
capacity of 
Unknown 3 G 3' 0.1 0.1 1.0 0.8
Background
Control 4 G 4' 0.2 1,0 0.8
Standard 5 S 5'
■
- 1.0 1.0
The relative amounts of Unknown sample, antibody serum and buffer
were added to each tube as shown. They were mixed and allowed to
incubate for 5 minutes before adding 1 ml of a solution of 7.5 ng/ml 
57
[ Co] B^2 iri O.IM phosphate buffer pH 7.5 to each tube, shaking and
57
incubating for a further 10 minutes. The [ Co] B^^ solution is
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is diluted with cold so that each 1 ml aliquot contains 
approximately 10,000 c.p.m.
The albumin coated charcoal suspension was then added to 
each tube, except 5 and 5', to adsorb any vitamin B^^ bound 
to protein. After 15 minutes incubation, all the tubes were spun 
at 10,000 g for 10 minutes and had 1 ml of their clear supernatant 
removed and counted in a well type gamma counter for 1 minute.
Tubes 1 § 1' gave a measure of the total binding capacity of
the unknown sample. Tubes 2 G 2' were controls which gave the
number of counts bound by the antibody serum. In tubes 3 G 3*
any I.F. activity was knocked out by the I.F. antibody serum,
therefore, they gave a measure of the non-I.F, binding capacity
of the unknown sample. Tubes 4 § 4* contained no protein binder
therefore, the supernatant should not contain any bound counts.
The 1 ml supernatant from these tubes thus gave a background count
which was subtracted from the counts given by the other tubes before
further calculation. Tubes 5 § 5* were the standards which gave
57
the total c.p.m. given by 7.5 ng [ Co] vitamin B^ ^^ * The average 
of the counts contained in the duplicate tubes was used in the 
calculations.
Thus the I.F. binding activity of the sample was given by the 
calculation : -
X = .(Tubes l. c .p.m.- Tubes 3 cpm Tubes 2.cpm). ^  lo x 7.5ng sample
Tubes 5 c.p.m.
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The total binding activity is given by :
Y = (Tubes 1 ^ 10 x 7.5 ng B /ml sample
Tubes 5 c.p.m.
Therefore, the percentage of I.F. binding activity in the sample 
is given by : -
-  X 100%
(Tubes 1 cpm - Tubes 3 cpm + Tubes 2 cpm) ^ X00% 
Tubes 1 c.p.m.
Any sample which had enough activity to bind all the counts 
available was diluted in O.IM phosphate buffer pH 7.5 and assayed 
again.
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COLLECTION AND PREPARATION_OF HUMAN ^ GASTRIC_JUICE
Gastric juice was collected on ice by naso-gastric suction 
from patients undergoing routine Maximal Acid Output tests for 
diagnostic purposes. The gastric secretion was stimulated by 
intramuscular injection of Pentagastrin in a dose of 6 pg/Kg 
body weight.
The juice was filtered through glass wool to remove excess 
mucus, cell debris and residual food particles. The pH was then 
raised to 10 by adding 5N NaOH and stirred continuously for 15 
minutes to destroy peptic activity. Then the pH was adjusted 
to 7 with IN HCl and assayed for Intrinsic Factor and Non-Intrinsic 
Factor binding activity. Only samples with greater than 85% I.F. 
activity were selected. These selected samples were filtered 
through sinta-glass Blichner funnels, porosity 3, to reduce viscosity 
and then either immediately subjected to affinity chromatography 
or stored at -20“C in approximately 400 ml aliquots. Sodium azide 
0 .02% w/v was added to the samples and to all buffers to help 
prevent bacterial growth.
-9? _H09_i 1? i „99599yi?^T§
For each affinity chromatography run, lOg of commercial-, freeze 
dried, dessicated hog gastric mucosa was reconstituted in 500 ml 
O.IM phosphate buffer pH 7.5. These components were stirred
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together continuously for 60 minutes at room temperature. ' The 
preparation was then centrifuged at 10,000 g for 15 minutes and 
the supernatant removed, filtered through a sinta-glass Buchner 
funnel, porosity 3, and immediately applied to an affinity 
chromatography column.
ISOLATION_0F _HUMAH_INTRINSIC_FACTOR
Samples of human gastric juice, collected and assayed as 
described above, which contained >85% I.F. activity were diluted 
1 : 1 in O.IM phosphate buffer pH 7.5 to reduce their viscosity 
and filtered through a sinta-glass funnel immediately prior to 
application to the affinity chromatography column.
The column of vitamin Sepharose was first washed with 
1 litre of O.IM Glycine Na-OH pH-10 and then with 1 litre of O.IM 
phosphate buffer pH 7.5 at room temperature. The gastric juice 
was pumped up the column from bottom to top at a flow rate of 
approximately 50 ml per hour. It was pumped up the column so that 
gravity counteracted, to some extent, the packing effect of the 
relatively viscous gastric juice. The amount of gastric juice 
which could be passed through the column was limited by the fact 
that at room temperature the gastric juice preparation was a good 
growth medium for bacteria and so despite reasonable precautions 
being taken, the effective maximum time that gastric juice could 
be run through any column was 48 hours. This meant that the
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maximum amount of gastric juice preparation which could be processed 
on any one column was 2.5 litres. The pumping speed could not be 
increased since it caused the column to pack tightly and thus 
inhibit the flow. A similar effect occurred when less buffer was 
used to dilute the sample, since, although this decreased the 
volume to be processed, the resultant increase in viscosity slowed 
down the flow and more than counteracted any possible benefit.
The samples were usually in approximately 400 ml aliquots, stored 
at -20*C. These were thawed in a 37°C water bath, filtered, 
diluted and kept at 4°C until required for the column, when they 
were allowed to reach room temperature. The column was not kept 
at 4°C while in .use because although the lower temperature would 
have slowed down bacterial growth, it also increased the viscosity 
of the gastric juice and slowed the flow through the column. Apart 
from this practical consideration, the column was deliberately run 
at room temperature since this temperature is closer to physio­
logical conditions.
After the gastric juice had been passed through the column, 
it was washed with 200 ml O.IM glycine - NaOH pH-10, 200 ml O.IM 
phosphate buffer pH 7.5 and then eluted with 5.0M Guanidine hydro­
chloride in O.IM phosphate buffer pH-7.5. After the void volume 
of eluant had passed from the column, collection proceeded. 
Approximately 90% of the recovered Intrinsic Factor was found in 
the first 30 ml of eluant after the void volume. This fraction 
was filtered through Whatman No. 3 filter paper to remove any 
Sepharose finings which were eluted by the high density of the
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Guanidine HCl, placed in neprophane dialysis tubing and dialysed 
against 15 litres distilled water at 4°C for 72 hours with water 
changes at 24 and 48 hours. The final preparation was assayed 
for I.F. : non-I.F. activity and stored in 1 ml aliquots at -20°C.
ISOLATION _0F _HOG _INTRINSIC _ FACTOR
The basic procedure was identical to above, using 500 ml of 
the Hog I.F. preparation, previously described, instead of human 
gastric juice. This isolation was faster because of higher 
initial I.F. concentration and thus lower total volume of the 
sample. Risk of infection and loss of protein by dénaturation, 
therefore, was reduced.
ASSAY_OF_INTRINSIC_FAfTOR_ACTTVITY_-_ÇIN_VIYO)
The biological activity of preparations of intrinsic factor
was assessed by measurements of the effect on the absorption of
cyanocobalamin by patients with pernicious anaemia. A double
tracer technique was used and the amounts of radioactivity
retained in the body two weeks after oral dosing was taken as a
measure of the cyanocobalamin absorbed. On the first day of
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the test the patient ingested 1.0 pg, 0.5 pCi [ Co] cyanocobalamin
57
in 100 ml water and 24 hours later 1.0 pg, 0.5 pCi [ Co]
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cyanocobalamin with the intrinsic factor preparation made up to 
100 ml in water. The patients fasted for twelve hours before 
and three hours after each oral dose. Whole body radioactivity 
was measured in a multidetector system housed in a steel room 
before and after each oral dose and finally two weeks after the 
dose. Counting rates were corrected for background radioactivity, 
natural body radioactivity, radioactivity decay and where required 
for the contribution of the[^^Co]to the counting rate in the [^^Co] 
energy band.
Experience with this technique and monitoring system has 
shown that patients with pernicious anaemia rarely absorb more than 
20% and never more than 28% of a 1 pg test dose. Normal subjects 
absorb an average of 50.6% of the dose (standard deviation 14.7)
(46) .
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RESULTS
MONOCARBOXYLIC_AEID_DERTVATTVE_OF_CYANOCOBALAMEN
Each major band of red material recovered from the ion 
exchange column was taken to dryness, weighed and had its radio­
activity measured. A typical set of results and the yield from 
each band, calculated from the dry weight are shown in Table 2.
TABLE 2 Yield of hydrolysis products from cyanocobalamin
Source dry weight (g) 
/
c.p.m. Yield %
Acid Hydrolysate 5 1,014,817 100
Biorex Eluate 968,673 95 ) ^c.p.m.^
Q.A.E. 1st Band 2.22 459,178 44.4
Q.A.E. 2nd Band 1.57 319,217 31.4
Q.A.E. 3rd Band 0.63 123,427 12.6
Q.A.E. 4th Band 0.1 21,381 2
Aqueous solutions (lOmg/ml) of each of the major bands, 
cyanocobalamin and monocarboxylic acid cyanocobalamin were 
prepared and 0.2 ml from each was spotted onto the Whatmann No. 3 
paper and ascending paper chromatography performed. The first 
band contained the unconverted cyanocobalamin and also various 
components which gave purple spots.and were not investigated 
further. The second band gave an identical Rf value to the
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monocarboxylic standard. The total material contained in this 
band weighed 1.57g and thus the yield of monocarboxylic acid 
recovered was 31.4% of the original cyanocobalamin. Band 3 and 
band 4 were assumed to contain di- and tri-carboxylic acids 
respectively (47) . There remained some minor bands of faint 
orange and pink colour on the Q.A.E. Sephadex column after the 
fourth major band had been eluted. These were discarded.
PREPARATION_OF AFFINITY^ADSORBENT
When the protocol described for the preparation of the affinity 
adsorbent was strictly adhered to, good yields of covalently bound 
cyanocobalamin were achieved (approximately 10% incorporation, as 
judged by radioactivity). However, if the pH levels quoted for 
the reactions were deviated from the yield fell off drastically.
Also when spermidine was used in place of 3, 3 diaminodipropylamine 
as the bridging chain, the yield was only about 2% incorporation. 
There was no apparent reason for this since the only difference in 
structure between the two compounds is that spermidine has one less 
CH^ group in its hydrocarbon chain.
The assay of a typical sample yields results as shown in 
Table 3. The reproducability of the assay was measured by storing
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a particular sample of neutralised gastric juice in 1 ml aliquots 
in plastic tubes at -20°C. One of these 1 ml aliquots was thawed 
and assayed every time an assay was being carried out until 25 
res^ults had been obtained. The coefficient of variance gained 
from these results was 6 .8 .
TABLE 3 Results of "in vitro" assay for I.F. activity.
Tube Description
c.p.m.
in 1 ml 
supernatant
Avetage 
c.p.m 
—  Background
1 40.29
Unknown Sample 3980
1 ’ 4163
2 239
Antibody Serum 112
2 » 217
3
Unknown Sample +
565
456
5'
Antibody Serum
579
4 120
Background -
4 ’ 112
S 5763
Standard 5706
S' 5882
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Tubes 1 cpc
Total binding of Sample = xuX>es 5 cpm ^ ^^12^^^ sample
3980
= X 75 ng B^2/ml sample
= 52.2 ng 8^2/#! sample
Tubes 1 cpm -■ tubes 3 cpm + tubes 2 cpm
Tubes 5 cpm
X 75
3980 - 456 + 112 ,
75 ng B^2/ml sample
5706
= 48 ng B^2/ml sample
48
X 100% 92%
52.2
COLLECTION_AND_PREPARATION_OF_HUM^^
After preparation and assay for I.F, activity, only samples 
which contained > 50 ng/ml 8^2 binding capacity which was > 85% 
I.F. mediated were further processed. Over the period of study 
approximately 40% of the samples collected were suitable, the 
others either having too low a concentration of I.F. or too high 
a proportion of non I.F. activity. Samples which could not be 
processed immediately, and were therefore stored at -20°C, showed 
no appreciable loss of I.F. activity over a 9 month period.
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ISOLATION OF HUMAN AND HOG INTRINSIC FACTOR
TABLE 4 - Typical results of Affinity Chromatography on human
gastric juice and reconstituted hog gastric mucosa
Volume
(ml)
Total
Protein
(mg.)
^12 
Binding 
Activity 
(pg 
B^2 bound)
I.F. 
Specific 
Activity 
(pg B12 
bound/mg 
protein)
Purifi­
cation
factor
Yield 
of I.F. 
(%)
Human
Gastric
Juice 2,500 6,740
(85% 
115.8 I.F) 0.0146
Final
Preparation 35 3.1
■ (94% 
56 I.F.) 16.9 X1163 52
Hog
Gastric
Mucosa 500 3,170
(35% 
400 I.F) 0.044
Final
Preparation 40 2.7
(96% 
61.2 I.F) 21.7 x493 42
As can be seen from the results in Table 4, affinity chroma­
tography is a very powerful tool in the purification of Intrinsic 
Factor. However, although all the non binding proteins passed 
easily through the column uninhibited, the binding proteins 
which do not exhibit I.F. activity presented a major problem.
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With human gastric juice the problem was partly overcome by 
only selecting juices with low non-I.F. content. This was not 
possible with the commercial hog preparation which contained 
approximately 65% non-I.F. binding activity. Initially the 
procedures for eluting the column . were performed very closely to 
those described by Allen et al (18) using 7.5M Guanidine-HCl ph 7.5 
and under these conditions there was no improvement in the ratio 
of I.F. : non-I.F. recovered. However, this procedure was later 
modified by using lower concentrations of Guanidine-HCl at different 
pH's and it was found that at a 5 Molar concentration at pH 7.5, 
predominantly I.F. was eluted from the column leaving the non-I.F. 
binders behind. Since the reported association constants for 
I.F. and non-I.F. binding to cyanocobalamin ( 1.5 x 10^^*M )^
are not significantly different (17, 18  ^48), it may be that the 
higher carbohydrate content of non-I.F.,approximately double that 
of I.F. at 35.5% of the molecular weight, rendered the non-I.F. 
proteins less susceptible to dénaturation under these conditions 
and thus they were not eluted from the column.
Assuming a molecular weight for I.F. of approximately 60,000 
the final binding activity of the Human I.F. preparation should have 
been given in a total protein weight of only 80% of that found.
The other 20% was probably accounted for by I.F. which failed to 
renature properly during dialysis giving a non-functional protein 
or even pieces of polypeptide. Some evidence for this was found 
using gel filtration (shown later).
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Since this small amount of non-functional protein was probably 
a function of the denaturation/renaturation part of the purification, 
it could not be removed by further application of the purification 
procedure. In experiments where it was attempted to process more 
than 2,500 ml gastric juice on one run, the percentage 6f non­
functional protein recovered rose drastically.
The total yield of I.F. was approximately 50% for both human 
and hog I.F. The initial gastric juice and hog mucosa preparations, 
tested after chromatography, contained ^  2% of their initial binding 
activity. Therefore, the loss of I.F. is not due to non-binding 
in the column. Some protein would denature spontaneously and be 
lost during the washing procedure and some would fail to be 
denatured during the Guanidine elution and thus stay on the column.
After the 5M Guanidine elution, the columns were further eluted 
with 7.5M Guanidine to wash out the non-I.F. proteins before further 
affinity chromatography was carried out on them.
Before it was discovered that I.F. and non-I.F, could be 
separated by eluting the column with a lower concentration of 
guanidine-HCl, the method of "Selective affinity chromatography" 
as used by Allen et al.(18) was investigated. This method used 
the monocarboxylic derivative of cyanocobalamin, with the nucleotide 
portion removed, bound to Sepharose-4B as the affinity adsorbent.
It depended on the property of non-I.F. binders to bind to this
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derivative of cyanocobalamin which lacked the nucleotide portion 
much more avidly than I.F. However, it was found that the increase 
in processing and the repeated denaturation/renaturation involved 
caused such a decrease in yield as to make this procedure impractical 
The only difference in the method used was to run the columns at 
room temperature instead of 4°C.
It was found that after any given column had been used more 
than approximately six times, pink material started to appear in 
the guanidine-HCl eluant. This material proved, under light 
microscopy, to be small pieces of the affinity adsorbent showing 
that some of the Sepharose-4B was disintegrating through usage.
The pink material could be removed by filtration of the 
guanidine-HCl eluant through Whatman No. 3 filter paper. However, 
when this disintegration of the Sepharose started, the efficiency 
of the columns decreased and they were discarded.
ASSAY_OF_I^F^_AfTTVITY__-__(IN_VIVO)
Some I.F. preparations which gave positive "in vitro" binding 
results were tested for biological activity in volunteers who were 
known to have pernicious anaemia. A dose of 30 pg I.F. preparation 
was used, as judged by the I.F. binding capacity "in vitro" of the 
given sample.
The results of the assay are given in Table 5. Each patient
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received an I.F. preparation from a different batch.
57
TABLE 5 - Retention of [ Co] cyanocobalamin in Pernicious
Anaemia patients using purified I.F. preparation,
% cyanocobalamin dose absorbed
Patient
Dose 
given alone
0.5 pCi ^^Co
Dose 0.5 ^Ci ^^Co +
30 pg Human I.F.
Dose 0.5 ptCi ^^Co + 
30 pg Hog I.F.
A 2 - 70% (100)
B 1.5 21 (31)
C 1 23 (34)
D 5 61 ( 90)
E 7 50 ( 74)
The increases in the amount of cyanocobalamin absorbed is lower
for the human I.F. preparation than the hog preparation. The
vitamin content of the various preparations was assayed using
a microbiological assay. For the hog I.F. preparations used the
level of vitamin B^^ less than 200 pg/dose whereas the I.F.
used had a level of more than 5,000pg/dose. This endogenous
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vitamin B^^ could have diluted the test dose of Co cyanocobalamin 
and thus reduced the amount of radioactivity absorbed. Patient 
C also underwent the same procedure using 50 mg of commercial hog
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I.F. (which is the amount used routinely to test vitamin 
absorption) in place of the purified preparation. This test 
gave an absorption of 25% which is not significantly different 
from the result with purified I.F. Therefore, either this patient 
had some cause for malabsorption other than a lack of I.F. 
production, or he did not fast for the prescribed period before 
and after ingestion of the test dose.
The values in brackets in Table 5 represent corrected 
absorption percentages. On a theoretical basis, if the molecular 
weight of I.F. is approximately 60,000 and that of cyanocobalamin 
in 1360, then 30 pg of I.F. has a maximum B^^ binding capacity of
0.68 pg. Thus the maximum possible absorption of B^^ was 0.68 pg 
or 68% of the 1 pg test dose, assuming a stochiometric 1 : 1 
relationship between I.F. and B^^ .^nd that each I.F. molecule only 
acts once (49, 50). Thus the values in brackets have been corrected 
on the basis that 68% absorption represents 100% of the total 
possible absorption.
It would have been desirable to carry out more absorption
tests with human I.F., but suitable patients were not available
57
in time. Patient B was also given a 1 pg test dose of [ Co] 
cyanocobalamin with 60 pghuman I.F., but this still failed to 
increase further the amount of dose"retained.
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DISCUSSION
Once the monocarboxylic acid derivative of cyanocobalamin had 
been prepared and purified it was a relatively simple procedure 
to bind it to the substituted Sepharose, The addition of the 
bridging chain to the Sepharose was also simplified by using the 
commercially available Sepharose-4B which had already been activated 
with cyanogen bromide, thus allowing this potentially noxious 
reaction to be missed out. The preparation could now probably be 
simplified further by employing a recent product of Pharmacia Ltd., 
which already has a 6 carbon bridging chain attached to it (AH- 
Sepharose 4B). This product was not tested. It is thus not 
possible to comment on whether the shorter hydrocarbon chain would 
affect the steric hindrance and thus the yield of I.F. bound or 
ndt. The low yields obtained by Oleson et al (35) using 
hydroxocobalamin covalently bound to albumin could possible be 
explained on the basis of steric hindrance caused by the albumin.
After the adsorbent had been used several times, the Sepharose 
tended to break up and finings of Sepharose with cyanocobalamin 
attached appeared in the guanidine-HCl eluant. This pink material 
was recognisable as damaged Sepharose under low power light 
microscopy. Although the bulk of this material could be removed 
by filtration, its appearance was invariably accompanied by decreased 
I.F. yields and increased cyanocobalamin concentration in the final 
preparation. This breakdown of the matrix was probably the result
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of bacterial attack despite the use of sodium azide. The 
appearing in the eluant was primarily cyanocobalamin and not the 
monocarboxylic derivative which proves that it had been bound to 
the terminal amino group of the bridging chain and that the bond 
between this amine and the hydrocarbon chain must have been broken 
to release native cyanocobalamin.
The criteria for being cyanocobalamin was that it supported 
growth of Lactobacillus Leichmanii in the microbiological assay 
and thus could not have been the monocarboxylic derivative which 
is not a metabolite of this organism.. Otherwise, the adsorbent 
seemed fairly stable.
The main difference between Allen's method and the ones 
employed in this study were : -
(i) Temperature. Allen carried out all his isolations 
at 4°C whereas room temperature was used for this 
report.
One reason for this was that cold room facilities were 
not available. However, this could have been overcome 
by running the column in a fridge, but when this was 
tried it was found that the decreased temperature 
increased the viscosity of the gastric juice or hog 
preparation and inhibited flow. Allen also carried
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out some of this I.F. characterisation on experiments 
at 4°C and it was felt that it was possible that arte- 
factual results might occur at this temperature. Thus 
it was decided to carry out all procedures at room 
temperature which is closer to physiological conditions.
The major drawback of this decision undoubtedly being 
the increase in bacterial activity. One exception to 
this rule was the dialysis of the guanidine-HCl eluant 
against water which was carried out at 4°C. It was 
found that higher yields of I.F, were gained at this 
temperature, possibly due to the slower and perhaps 
more accurate renaturation of the protein,
(ii) Allen used a gravity feed for his column but it was 
found that a high enough flow rate (50 ml/hr) could 
not be achieved by this method. Thus it was necessary 
to pump the fluid through this column. It must be 
assumed that Allen's preparation somehow decreased
the viscosity of the sample.
(iii) Allen used a process of "selective affinity chromatography" 
to separate I.F. from non-I.F. hog binding proteins. 
However, this method did not prove to be practical in
the present study. On employing the technique, it was 
found that the affinity adsorbent lacking the nucleotide 
portion of the cobalamin molecule, failed to effectively
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resolve the I.F. and non-I.F. binders and also that 
the additional processing of the material caused 
drastic reduction in the final yield of protein.
By adjusting the molarity of the guanidine-HCl used 
to elute the protein, it was discovered that when 
using 5M guanidine-HCl instead of 7.5M a high proportion 
of I.F. was .eluted, leaving the non-I.F. bound to the 
column. This was a considerable simplification on 
Allen's technique and appeared to be effective. As 
was stated in the results section, the relative affinities 
of hog I.F, and non-I.F. for not significantly
different, therefore it must be assumed that hog non-I.F. 
has a more stable structure than I.F. under these elution 
conditions and that it is not denatured sufficiently to 
break its bond with the affinity adsorbent. The most 
significant difference so far reported (18) is the 
higher carbohydrate content of non-I.F. This may 
protect it to a certain extent from the unfolding action 
of the guanidine-HCl.
When the 5M concentration was used to elute human I.F., 
it was also found that the proportion of non-I.F. binders 
was reduced.
There was the added advantage that 5M guanidine-HCl 
was obviously not quite such a drastic dénaturant as
7.5 Molar.
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In general the specific activity of the final preparations of 
I.F. (pg hound/mg protein) were slightly lower than those found 
by Allen, usually in the range 16-25 pg B^2 bound/mg protein.
This presumably depended on the quality of the starting material 
and the efficiency of the affinity chromatography column at the 
time. However, the highest yield of I.F. recovered was 
approximately 55% whereas Allen claims yields of over 80%. No 
explanation for this was found except that perhaps the higher 
temperature caused faster spontaneous dénaturation of the I.F. 
or that the 5M guanidine-HCl failed to eluate all the I.F. from 
the column. However, when a given column was subsequently eluted 
with 7.5M guanidine-HCl, no appreciable further I.F. activity was 
recovered.
Even allowing for this reduced yield, this method still 
showed a marked improvement on results gained using more 
conventional multi-stage purification systems. A feature of 
previous purification methods was the saturation of the B^2 
binders with radioactive Cobalt label, thus allowing the 
purification to be followed by monitoring the behaviour of the 
radioactivity (21, 51). This yields a product which is an 
I.F.-6^2 complex and is thus not suitable for some experimentation, 
Although this B^2 could be removed using guanidine-HCl (see later), 
this would further decrease the overall yield.
The glycoprotein recovered by this method could be shown
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to be immunological identical to I.F. in that its binding 
was >  95% destroyed by serum from pernicious anaemia patients 
which contained I.F. antibodies and also it was biologically 
active at a 30 yig dose level. The results for the biological, 
activity of human I.F. were not as convincing as for hog I.F. 
and would have been desirable to have carried out more trials.
From the total protein measurements and the specific 
activity calculations it is clear that the substance isolated 
is a very pure preparation of I.F, and the impurities are 
probably partially denatured I.F.
This method does not require any very elaborate or 
expensive equipment and so could be universally used to purify 
binding proteins.
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CHAPTER III
PHYSICO-CHEMICAL PROPERTIES OF PURE HUNÎAN  ^HOG INTRINSIC FACTOR
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Although there have been reports (31, 52) on the properties 
of Intrinsic Factor, many of these have been conflicting and very 
often in the literature the phrase appears "this work needs to be 
'repeated on a pure I.F. preparation".
Neither the time nor the facilities were available to cover 
all or even most of the properties of pure I.F. in this study.
The results which were obtained appeared to be reproducable among 
the different batches of I.F. prepared and except where specifically 
stated, there was no significant difference found between the 
behaviour of the human and the hog preparations.
Parallel results for each individual result obtained were to 
be found scattered in the literature, but the range of results 
quoted in the past is so extensive that it was difficult to make 
meaningful comparisons, especially where previous work was carried 
out on impure or partially pure preparations.
b in ding c a p a c i t y of I.F. AND CRITERIA OF PURITY
The total B^2-binding capacity of the final I.F. preparation 
was found by serially diluting a sample from the preparation and 
subjecting the various dilutions to the "in vitro" I.F. activity 
assay.
The purity of a given sample was judged by the percentage of 
the Bj2"binding activity which was blocked by the addition of serum
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from pernicious anaemia patients containing I.F. antibodies and 
also the specific activity of the sample found by dividing the 
total binding capacity of the sample in micrograms by the 
total protein contained in the sample in milligrams.
At a later stage in the study, after antibodies to pure I.F. 
preparations had been raised in rabbits (see Chapter 4), these 
antibodies were used to check the percentage of I.F. in a given 
preparation in preference to the pernicious anaemia patient serum.
Some of the less pure I.F. preparations which were made 
displayed properties which might have given rise to the conflicting 
results found in the past.
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SECTION I
DETERMINATION OF_M^LECULAR_WEIGHT_0F_I.F._BY GEL_FILTRATION^ON 
SEPHADEX G-200
A sample of 1 ml, 100 I.F. preparation in O.IM Tris-acetate
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buffer was pre-incubated at room temperature with excess [ Co] 
cyanocobalamin for 30 minutes, then the excess cyanocobalainin was 
removed using 1 ml albumin coated charcoal and centrifugation.
The clear supernatant was counted for total activity, adjusted to 
4 ml with O.IM tris-acetate buffer pH 7.8 containing IM NaCl and 
applied to a Pharmacia column 55 cm x 2.5 cm containing Sephadex 
G-200. The sample was pumped up the column in the same Tris- 
acetate buffer by an LKB peristaltic pump at a flow rate of 12 ml/hr 
The column eluant was passed through an LKB Uvicord II ultraviolet 
absorptiometer which passed a continual reading of the U.V. 
absorption at 260 nm to an LKB multichannel pen recorder. The 
eluant was collected in 6 ml fractions on an LKB Ultrorac 
automatic fraction-collector.
57
The samples were labelled and counted for Co activity on a 
Packard Autogamma Scintillation Spectrometer for 2 minutes each.
Dextran Blue was used to find the void volume of the column 
and pure commercial protein preparations used to calibrate it. 
These proteins had the following molecular weights :-
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myoglobin (B.D.H.) - 16,000; pepsin (Sigma) - 34,000;
bovine serum albumin (B.D.H.) - 66,000; haemoglobin (B.D.H.) - 65,000;
aldolase (Sigma) - 150,000; phosphorylase A (Sigma) - 360,000.
The experiment was carried out under these conditions for 
both Human and Hog I.F. and was also carried out in a similar
manner with Hog I.F. except that the I.F, was pre-incubated with
57 o
the [ Co] cyanocobalamin at 4 C for 24 hours.
Also 100 jug of pure hog U.F. which had been labelled with
125
I (description later) was applied to the G-200 column. This
was carried out to check the molecular weight of I.F. alone, not
complexed to cyanocobalamin.
The U.V. absorption at 260 nm of the fractions was read on 
a Unicam S,P. 1800 spectrophotometer against a blank of elution 
buffer.
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RESULTS
When a high purity sample of I.F. (% I.F,> 95%, specific
activity >  25 ug bound/mg protein) was saturated with [ Co]
cyanocobalamin and applied to a Sephadex G-200 column as described,
57
a single binding peak of [ Co] was found as shown in Graph 2.
U.V. absorbance22i-
1 61 “ Bovine
Serum -B
Albumin
o
Blue
Dextran
6 - •
2 •-
120 24060 180
■“ 1.0
0.5
elution volume (ml)
GRAPH 2 - Elution pattern of Blue Dextran and bovine serum albumin
as judged by U.V. absorbance and of I.F.-B^g complex as 
judged by radioactivity.
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This same column was calibrated with pure proteins of known
molecular weight. The void volume was taken to be the elution
volume of Blue Dextran (Vo) and the elution volume of each of the
other proteins was taken as the volume of eluant up to the centre
of the absorbance peak for each individual protein (Ve), The 
Ve
ratio /Vo was plotted against the log of the accepted molecular 
weight of each of the proteins to yield Graph 3.
3.0
2.5
2.0
1.5
1.0
Ve
/Vo
Myoglobin
Pepsin
Bovine Serum AlbuminHaemoglobin
Aldolase
Muscle Phosphorylase A
Blue
Dextran
10
GRAPH 3 -
10 ' 10
molecular weight (Log Scale)
Graph of relationship of Molecular_Weight to elution 
volume on 2.5 cm x 55 cm Sephadex G-200 column
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Taking the results of ten runs through the column of pure hog 
and human I.F.— complex, a value of ^®/Vo 2.04 with a standard
deviation of - 0.03 was found which, when applied to graph 3 gives 
a molecular weight of 56,000 - 2,000. The samples of I.F. applied 
to the column were adjusted to contain 100 ^g total protein. They 
had an average binding capacity of 25 jig bound/mg protein. 
Therefore each sample contained 2.5 pg B^^ which is a ratio of 
weights of 100 •: 2.5 = 40 : 1. This means that one molecule of 
I.F. binds one molecule of B^^ (molecular weight = 1360) then the 
theoretical molecular weight of I.F. is 54,000. This suggests that 
the experimental molecular weight found must be that of an I.F. 
monomeric form.
Both hog I.F. and human I.F. gave the same molecular weight 
when bound to cyanocobalamin.
Some samples of pure hog I.F. were allowed to incubate with 
excess cyanocobalamin for 24 hours at 4°C before gel filtration, 
but the elution pattern of the bound radioactivity was not changed. 
There was no evidence of oligomer formation which would have 
introduced a component with higher molecular weight.
When some pure hog I.F. had been successfully labelled with 
[125ij (ggg Chapter 5), 100 ^ g of the preparation was column 
chromatographed in the absence of cyanocobalamin. This was 
repeated twice and each time the ^®/Vo value was slightly lower
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than the mean of the value for the complex, suggesting a
higher molecular weight (approximately 64,000]. This seems unlikely 
but could be explained on the basis of change of configuration of 
the molecule i.e. if the I.F. were more loosely coiled when not 
bound to 8^2 ' This would be in agreement with the results of 
Grasbeck in 1967 (53) and Hippe in 1970 (54) who found that the
o
Stoke's radius of the I.F. molecule decreased by 4A when cyanocobalamin 
bound to it.
When some I.F. preparations which had lower percentages of
57
I.F. activity were labelled with [ Co] cyanocobalamin and applied 
to the column, a typical elution pattern with two converging peaks 
was found as shown in Graph 4.
20 r
Peak B
o
Peak A-
24018060 120
elution volume (ml)
GRAPH 4 - Elution pattern of an I.F. preparation which had lower
I.F. specific activity
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Peak B in Graph 4 had a ^®/Vo value of 2.05 which gives it 
a molecular weight of 56,000. Peak A has a ^^/Vo value of 1.72 
which gives it a molecular weight of approximately 100,0 0 0,
The fractions from the centre of peak A were pooled as were 
the fractions from the centre of peak B. The volume of each 
pool was reduced to approximately 2 ml by ultrafiltration using an 
Amicon PM-10 membrane. They were then run against I.F. antibody 
on Ouchterlony plates (for protocol - see Chapter 4).
The sample from peak B precipitated with the antibody, whereas 
the sample from peak A did not.
This suggests that peak B probably contained I.F. whereas 
peak A probably did not, but was a contamination caused by non-I.F. 
binders being eluted from the affinity chromatography column. It 
is possible, however, that peak A was a dimerised form of I.F. and 
that the antigenic sites were altered by this process, but that 
seems unlikely.
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SECTION 2
ULTRAFILTRATION
An Amicon Ultrafiltration cell, using membranes of differing 
retentivity was used in various experiments.
A PM-10 membrane which retains molecules ^ 10,000 M.W. was 
used to concentrate samples of I.F. This membrane was also used 
to alter the type of buffer medium in which the I.F. sample was 
contained if this was necessary in any operation, e.g. any I.F. 
sample being subjected to gel filtration was transferred to O.IM 
Tris-acetate buffer pH 7.8 containing IM NaCl.
An XM-50 membrane which retains molecules>50,000 M.W. was 
used to remove any "protein debris" i.e. pieces of polypeptide 
which were the result of the dénaturation during the elution of v 
the column. This type of membrane was also used in an experiment 
to remove any cyanocobalamin bound to the I.F. molecules as a
result of hydrolysis of cyanocobalamin from the affinity adsorbent.
57The experiment was carried out by adding 6.6 ng, 0.1 ^Ci [ Co] 
cyanocobalamin to 30 ml of the guanidine-HCl eluant and incubating 
for 30 minutes before placing the eluant in the ultrafiltration 
cell and applying a positive pressure of 350 KPa Nitrogen. The 
cell was stirred continuously until the volume of the sample had 
been reduced to approximately 2 ml. The pressure was released and
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a further 30 ml of 7.5M guanidine-HCl added and the pressure 
re-applied. This operation was repeated four times and all the 
filtrate was collected and counted for radioactivity. After 
ultrafiltration the sample was removed from the cell and dialysed 
against water as was described in Chapter 2.
57
A rough approximation of the molecular weight of I.F.-[ Co]
cyanocobalamin complex was attempted by using a range of membrane
retentivities consecutively on the same sample. The filtrate from
57each membrane was tested for [ Co] activity then the retained 
sample was restored to its original volume with fresh buffer and 
applied to the membrane of the next highest retentivity. Used
membranes were also counted for any bound activity.
If activity appeared in the filtrate from a given membrane
then albumin coated charcoal was added to the filtrate, incubated
for 15 minutes and centrifuged at 10,000g for 15 minutes to remove 
57any free [ Co] cyanocobalamin. If the activity was left in the 
supernatant then it had been shown to be bound to protein. PM-10,. 
XM-50, XM-100 and XM-300 membranes were used giving ranges of 
> 10,000;> 50,000; > 100,000 and >300,000 molecular weight retentivity 
respectively.
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RESULTS
When the final I.F. preparations were assayed for content 
it was found that they contained low amounts of endogenous B^g» 
These values varied from preparation to preparation but tended to 
be higher for human than for hog I.F. and also increased with 
usage of any given column. The range was from 2 pg I.F. -
1.5 ng I.F. Since 1 ^g I.F. would be theoretically capable
of binding approximately 23 ng of B^2, this range represented 
8.7 X 10^% - 6.5% of the total B^^ binding capacity of the I.F.
Thus the preparations with B^^ content in the upper part of 
the range would contain a significant proportion of I.F. molecules 
complexed to B^^-
Where it was required to have an I.F. preparation free from 
B^2 repeated ultrafiltration with an Amicon XM-50 membrane and 
7.SM guanidine-HCl was used as described.
The efficiency of this procedure and the effect on the I.F.
preparation was checked by repeating the experiment on samples of
57
I.F. with 50 ng cyanocobalamin containing 0.1 jJiCi [ Co] cyano­
cobalamin added.
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TABLE 6 - The effect of successive ultrafiltrations in 7,5M
guanidine-HCl in O.IM phosphate buffer pH 7.5 through
an Amicon_XM“50 membrane at 350 KPa positive pressure
with continual stirring on the bound B^^ content of I.F, 
and the total binding capacity of I.F.
% of total 
activity
% of total
[ Co] activity 
after 
coated charcoal 
treatment
Total 
Cyanocobalamin 
binding 
capacity 
(ng B^2 bound)
Total [^^Co] activity 
added to I.F. 100 98 212
Activity in 1st Filtrate 35.9 0 0
Activity in 2nd Filtrate 33.2 0.5 0
Activity in 3rd Filtrate 19.0 0.5 0
Activity in 4th Filtrate 2.9 0 0
Activity stuck to 
XM-50 membrane 1.3 - -
Activity retained inside 
cell 7.6 7.5 161
Thus, as can be seen from Table 6 , although the exposure to 
guanidine-HCl and ultrafiltration procedure could remove over 90% 
of the B^2 from the I.F. preparation, tho total binding capacity
had been reduced by approximately 25% . This was probably due to
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irreversible dénaturation caused by the guanidine-HCl concentration.
The percentage of which was retained in the cell after 
four successive ultrafiltrations was only slightly reduced by 
further repetitions of the procedure. Thus even in its partially 
denatured form, the I.F. retains some B^^ binding activity.
As can be seen from the percentage of activity left in the
various fractions in Table 6, after treatment with albumin coated 
57charcoal the [ Co] activity inside the cell was not affected and
57thus protein bound, whereas the [ Co] activity which appeared in 
the filtration was removed by the charcoal and was thus not protein 
bound but free B^2 *
The results from the experiment to find the approximate molecular 
weight range of I.F,-B^2 complex are shown in Table 7.
57TABLE 7 - Percentage of [ Co] cyanocobalamin-I.F. complex passing
through a range of Amicon ultrafiltration membranes in
O.IM phosphate buffer pH 7.5 with positive pressure and 
continual stirring.
M.W.
Retentivity
% total bound 
57
[ Co] activity 
appearing 
in filtrate
% filtrate activity 
removed by charcoal
PM-10 lo"^ 0.42 99
XM-50 5 X 10^ 0168 97
XM-100 10^ 81 2
XM-300 3 X 10^ 96 1.5
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Table 7 shows that 81% of the complex passed straight
through an XM-100 membrane while none passed through an XM-50
membrane. In fact, when the XM-100 membrane had a further 30 ml
of phosphate buffer passed through it, a further 18% of the total 
57
[ Co] activity appeared in the filter. Therefore, in effect, 99% 
57of the total [ Co] activity, which was shown to be protein bound 
by the albumin coated charcoal technique, could pass through the 
XM-100 membrane.
Thus the molecular weight of the I.F.-B^g complex must lie in 
the range 50,000-100,000.
I*F. preparations which had lower specific activities 
( < 2 0  ug B^2 bound/mg protein) and gave elution patterns similar 
to that shown in Graph 5a were ultrafiltered using an XM-50 
membrane and a further sample subjected to gel filtration on the 
G-200 column (Graph 5b).
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As can be seen from comparison of Graphs 5a and 5b, the 
contaminating material could pass through the XM-50 membrane 
thus effectively purifying the I.F. preparation and increasing 
its specific activity.
This material was presumed to be denatured protein pieces 
caused by the guanidine-HCl. It had some binding activity 
which could not be blocked by I.F. antibody.
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SECTION 5
STABILITY OF I.F. OVER A_PERIOD_OF_TIME_AT_DIFFERENT_pH
An aqueous sample of 2 ml, 100 j.ig I.F. was incubated with 
57
5 pig 0.1 juCi [ Co] cyanocobalamin for 30 minutes. The excess
cyanocobalamin was removed with albumin coated charcoal and
centrifugation for 15 minutes at 10,000g. The supernatant was
removed and 0.1 ml aliquots injected into each of a series of
test tubes set up in duplicate over a range of pH. Each tube
contained 1.5 ml distilled water which had been previously adjusted
to a certain pH value using either HCl or Na^OH. The pH values
used were:- 2; 4; 5.5; 7; 9; 10.5 and 12.5. The timing of the
experiment commenced when the 0.1 ml I.F. was added to each tube.
Samples of 0.1 ml were taken and added to 1 ml albumin coated
charcoal at 5 minutes, 20 minutes, 2 hours, 24 hours, 2 days and
7 days. These samples were spun at 10,000g for 15 minutes and
57
0.5 ml of the clear supernatant removed and counted for[ Co] 
activity. Any decrease in the amount of counts present was taken 
to show dénaturation of I.F.
This experiment was also carried out in a similar manner, 
except that the I.F, was incubated at the various pH's without 
the presence of cyanocobalamin. When the samples were taken at 
the specified time intervals, a standard "in vitro" assay of I.F. 
binding activity was carried out on them as described in Chapter 2.
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RESULTS
Both hog I.F. and human I.F. behaved very similarly when 
subjected to a range of pH values at room temperature over a 
period of time up to seven days. They were both stable between 
pH 6.5 - 10.5 and at pH 10.5, the I.F. retained almost 100% 
activity even after seven days. The results are shown in Graph 6
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GRAPH 6 The effect of pH on stability of the I.F.-8^2 complex 
at room temperature,over a period of time.
14
This graph shows that in the absence of proteolytic enzyme, 
I.F. is very stable between pH 6 and pH 10.5. Below pH 4 and 
above pH 12 the cyanocobalamin binding capacity falls off quite 
rapidly. The results shown in Graph 1 are the average of two
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sets of experiments using both human and hog I.F.
When a similar experiment was carried out but with the I.F, 
being incubated at the various pH’s without cyanocobalamin, the 
results were slightly different. Whereas in the above experiment 
the physical state of the I.F. was judged by the amount of labelled 
cyanocobalamin still protein bound, in this experiment the state 
of the I.F. was judged by the amount of labelled cyanocobalamin 
still capable of being bound after the incubation time. The 
results are shown in Graph 7, where 100% I.F, binding was taken 
as the amount of labelled cyanocobalamin a sample of the I.F. 
preparation at pH 9 could bind at time zero.
100
mins.
hour
binding 60 
activity
40
30 day
week
2 3 4 5 6 7 8 9 10 11 12 13
pH
GRAPH 7 - The effect of pH on the stability of I.F. in the absence
of room temperature over a period of time.
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A comparison of Graph 6 and Graph 7 show that I.F. appears 
to be more stable to pH when it is complexed with cyanocobalamin. 
Any difference in the percentage activity on the two shorter time 
intervals may be due to the slightly different method required to 
assess a B^2-binding capacity. However, over the two longer time 
intervals, the shape of the binding curve changes, suggesting that 
this is a genuine effect.
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SECTION 4
REVERSIBILITY^OF THE_pH_INACTIVATION_OF_I^F^_BINDING_ACTIVITY
In this experiment samples of I.F. were incubated at 37°C 
at the extremes of the pH range of the previous experiment, 
namely 2, 4, 10,5 and 12.5. The samples were incubated at body 
temperature for 30 minutes which was judged to be a reasonable 
time which I.F. might be subjected to acid pH in the normal stomach. 
After this time, two 0.1 ml samples were removed from the incubation 
tubes, one of which was taken to pH 7.5 by the addition of 0.5 ml
0.1M phosphate buffer, the other had 0,5 ml of distilled water 
added. Both samples were then immediately subjected to an 
"in vitro" assay of I.F. activity.
RESULTS
The experiment was carried out on the same concentrations of
1.F, as used in the time experiments above. The I.F. was not 
complexed to cyanocobalamin for two reasons :
(i) to allow the "in vitro" I.F. assay to be carried out 
on the samples.
Cii) To observe how the I.F. would behave under physiological 
conditions, i.e. leaving the acid environment of the 
stomach to the near neutral environment of the intestines 
when it was not complexed to B^^ .^nd in the absence of 
proteolytic enzymes.
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The results are shown in Table 8 .
TABLE 8 - Percentage of total B^g-binding activity of I.F. after
gH exgosure at 37°C for 30 minutes, with_and without 
restoration of neutral pH before assay.
pH
binding capacity of Human § Hog I.F. (%)
assayed in 
distilled water phosphate buffer pH 7.5
2 15 82
4 41 89
10,5 89 98
12.5 33 ___“_ J
All the samples showed a marked improvement in binding 
activity when they were returned to pH 7.5 before assay. However, 
the high alkaline pH (12.5) appeared to have a more permanent 
denaturing influence than the extreme acid pH.
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SECTION 5
RATE_OF EXCHANGE_Of_FREE_CYANOCOBA^AMTN_WITH_I.F^_BOUNm 
CYANOCOBALAMIN
57
Pure I.F, (100 ^ g) was pre-incubated at 37*C with excess [ Co]
cyanocobalamin (10 p.g) o£ known specific activity in 5 ml O.IM 
phosphate buffer pH 7.5. After 15 minutes the excess cyanocobalamin 
was removed using 5 ml albumin coated charcoal and centrifugation.
Two 3 ml aliquots of the clear supernatant were removed and 
counted for radioactivity. This result gave a measure of the 
cyanocobalamin bound to the protein. An equal quantity of 
unlabelled cyanocobalamin was added to each tube in a volume of 
1 ml and both tubes were placed in a water bath at 37°C. Samples 
of 0.1 ml were removed from both tubes at 30 minute intervals up 
to 8 hours, then one sample at 16 hours and one sample at 24 hours. 
When each sample was taken it was immediately added to 1 ml 
albumin coated charcoal, incubated at room temperature for 10 
minutes and centrifuged at 10,000g for 15 minutes. The clear 
supernatant was counted for radioactivity.
The experiment was then repeated using double the amount of 
unlabelled cyanocobalamin and then again using nine times as much 
unlabelled cyanocobalamin as labelled cyanocobalamin bound to the 
I.F. The results of the counts found in the supernatants of the
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timed samples were expressed as percentages of the total number of 
counts bound to the I.F. at time zero.
A control tube was also set up which also contained 3 ml of
57
the [ Co] labelled I.F. preparation, but to which 1 ml of buffer 
had been added which did not contain any unlabelled cyanocobalamin, 
Samples were taken from this tube at the same time as the other 
tubes and treated in the same way. This control was to check for 
dénaturation of the I.F. causing artefactual decreases in the 
labelled cyanocobalamin found in the supernatant after charcoal 
treatment.
RESULTS
When the results of the competition between the increasing
amounts of unlabelled free cyanocobalamin and the fixed amount 
57of [ Co] labelled cyanocobalamin bound to I.F. were compared on 
the same graph, (Graph 8) it was shown that there was a continual 
exchange between free and bound cyanocobalamin and that the rate 
of the exchange was dependant on the concentration of free 
cyanocobalamin present in the reaction mixture.
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Comparison of_the rates of exchange of_free and I.F, 
bound cyanocobalamin with increasing_concentrations 
of free cyanocobalamin.
Since it is known that I.F. will achieve its maximum binding 
capacity of cyanocobalamin in the presence of excess cyanocobalamin 
in approximately 20 seconds (52), the rate limiting step for the 
exchange of free and bound cyanocobalamin must be the release of 
the bound form from the I.F. molecule. The maximum rate for this 
step had not been reached at the 9-fold excess of free cyanocobalamin, 
where if the initial reaction rate was extrapolated, there would
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be 100% turnover of cyanocobalamin bound to I.F. in less than 
2 hours.
The theoretical equilibrium level between labelled and 
unlabelled, for all three concentrations of unlabelled, had 
been over 80% achieved by 8 hours of incubation and nearly 
100% by 16 hours.
57
The amount of [ Co] bound to I.F. in the control tubes 
had only fallen a few percent by 24 hours. Therefore, the 
disappearance of bound radioactivity from the supernatant of the 
samples was not due to dénaturation of the I.F.
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SECTION 6
AMINO-AClD_ANb_CA&BOHYDRATE_ANALYSIS
A sample o£ pure hog I.F. prepared by this method of affinity 
chromatography was subjected to amino-acid and carbohydrate 
analysis by Dr. G. Leaf, Department of Biochemistry, University of 
Glasgow.
A total of 120 jug of protein (as judged by the Lowry method) 
was hydrolysed -
(a) with 2.0 ml 6M HCl at 115°C for 16 hours
(b) with 0.5 ml 3M methane sulphonic acid at 110°C for 16 hours 
in an evacuated sealed tube. Dissolved air was removed by repeated 
freezing and thawing under vacuum.
The analyses were performed on a Jeol 105C amino acid analyser 
using the conditions described by Benson et al (55) except that the 
temperature was maintained at 70°C throughout.
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RESULTS
The results of the amino acid analysis using the two different 
conditions of hydrolysis are shown in Table 9.
TABLE 9 - Amino-acid and carbohydrate analysis of 120 jxg pure hog
I.F. using two different conditions for hydrolyses
a) with 2.0 ml of 6M HCl at 115“C/16 hours
b) with 0.5 ml 3M methane sulphonic acid at 110°C/I6 hours
AMINO-ACID
NANOMOLES
(a) (b)
Lysine 63.5 57.0
Histidine 20.4 20.2
Arginine 51.8 49.0
Aspartic Acid 97.0 106.1
Theonine 66.3 # 64.3 #
Serine 67.4 72.5 #
Glutamic Acid 106.0 106.9
Proline 78.5 71.3
Glycine 85.1 83:5
Alanine 76.1 85.2
Cystine 8.1 9.7
Valine 54.3 39.5 *
Methionine 16.3 19.4
Leucine 92.3 87.4
iso-Leucine 55.2 37.2 *
Phenylalanine 33.7 31.8
Tyrosine 29.6 30.1
Carbohydrates
Glucosamine - 33.8 #
Galactosamine -
# corrected for destruction during hydrolysis
* recoveries expected to be low for this type of hydrolysat;
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The specific activity of the hog I.F. was 30 ng binding/ 
mg protein.
Therefore, if we assume approximately 90% yield for the amino 
acid hydrolysis, then 108 of hog I.F. could bind 2.38 nanomoles
of B^2 ' By dividing the individual quantities of each amino acid 
shown in Table 9, a value is given for the number of nanomoles of 
amino acid present in the protein when it binds 1 nanomole of B^^* 
Since it has already been established that 1 molecule of I.F. binds 
1 molecule of the figures found are numerically equal to the
number of residues of each amino acid per mole of bound B^^* These 
figures are shown in Table 10 and compared with the result of 
Allen et al (18) for the same protein.
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TABLE 10 - Comparison of the amino acid and carbohydrate
composition of the hog I.F. purified in the present 
study and that of Allen et al.
AMINO ACID
Residues per mole of bound B^^
Present Study Results # Allen et al
Lysine 24 17
Histidine 8 9
Arginine 21 12
Aspartic Acid 45 50
Theonine 27 37
Serine 31 36
Glutamic Acid 45 48
Proline 30 31
Glycine 35 25
Alanine 36 32
Cystine 8 9
Valine 23 26
Methionine 8 10
Leucine 37 43
iso-Leucine 23 25
Phenylalanine 13 14
Tyrosine 13 9
Carbohydrates
Glucosamine 14 12
Galactosamine - 8
# These results are calculated from the results in Table'9b except 
for Valine and iso-leucine whose results were thought to be low for 
this hydrolysate, and the values for them shown in list (a} were used
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The amino acid results are fairly comparable between the two 
sets of results. The values for Lysine, arginine and glycine are 
rather higher than those found by Allen et al and the Threonine 
value is somewhat lower.
The more striking difference was the failure to demonstrate 
the presence of galactosamine at all in the present hog I.F. 
preparation.
Gas liquid chromatography was not performed on the hog I.F., 
therefore no value was found for the Fucose, Galactose or mannose 
concentrations. Similarly, no value was found for Tryptophan or 
Sialic Acid.
The molecular weight of the residues shown in Table 10 is 
56,230 which compares favourably with the molecular weight of the 
corresponding Allen results (56,776).
If a correcting factor is added for the missing results, based 
on the results found by Allen, then the molecular weight of hog 
I.F. including amino acid and carbohydrate would be approximately 
64,500.
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DISCUSSION
The molecular weight of both human and hog I.F. was found to 
be approximately the same both by ultrafiltration and gel filtration. 
The ultrafiltration put the value between the limits of 50,000 and
100,000 but was not capable of any further resolution. Using gel 
filtration on Sephadex-G200 the value of 56,000 t 2,000 was found 
for I.F .-cyanocobalamin complex and approximately 64,000 for I.F. 
alone. This discrepancy probably means that the I.F. molecule 
changes configuration slightly when bound to taking up a more
tightly spherical shape. This is consistent with the concept of 
Grasbeck (S3) that the B^^ molecule fits into a pit in the I.F. 
molecule.
These molecular weight values are in reasonable agreement with 
the value found from amino acid analysis and agree with the values 
found by Allen et al for the monomeric forms (17,18). This group 
did find a lower molecular weight - 44,200, for human I.F. by 
amino-acid analysis although the gel filtration value was 66,000.
At no time in the present study was evidence for a higher 
molecular weight form of I.F. found, i.e. a dimer or oligomer, 
either using ultrafiltration or gel filtration. These forms have 
been found by Allen et al and by Highley et al (56) who claim dimers 
of I.F. form slowly in the presence of high concentrations of I.F., 
but even when the present preparations were allowed to incubate 
for 24 hours with excess B^^» dimers were found. This is
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probably a much longer time than I.F. will exist for in a 
physiological environment. Therefore dimers can have no useful 
function.
Higher molecular weight binding protein was found in some 
less pure preparations, but it did not have the immunological 
identity of I.F., since it would not form precipitin lines with 
I.F. antibody on Ouchterlony- plates.
The other possibility exists that the lower molarity of the 
guanidine-HCl used to elute the affinity chromatography columns in 
the present work, only elutes a species of I.F. with an incomplete 
complement of carbohydrate. This decreased carbohydrate content 
making this I.F. more susceptible to partial dénaturation thus elution. 
This would explain the failure to detect any galactosamine during 
carbohydrate analysis. If this were so, it may mean that the 
carbohydrate part of the glycoprotein is responsible for oligomer 
formation. It is quite feasible that the carbohydrate content of 
the individual I.F, molecules varies quite considerably since this 
part of the molecule is added enzymically after the protein part 
has been synthesised. This might also explain the microheterogeneity 
of I.F. preparations on isoelectric focusing (57,58) which showed up 
to seven separate components in the work done by Grasbeck.
Some workers have found the molecular weight of human I.F. to 
be over 100,000 (59, 60) but this can only be explained on the basis 
of the present work if their preparations contained a high
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proportion of non-I.F, binders or if they did possess an oligomerised 
form.
Ultrafiltration was found to be a useful tool for increasing 
the specific activity of the final preparations and for removing 
"protein debris". Some of thé smaller molecular weight material, 
presumed to be fragments of I.F,, contained residual binding 
activity but this could not be blocked by I.F. antibody.
Both the pure I.F. preparations were very stable in the absence 
of proteolytic enzymes over a period of time between pH 6 and 10.5, 
Below pH 5 and above pH 11.5 their B^^ binding ability fell off quite 
rapidly. A comparison of Graph 6 and Graph 7 suggests that the 
I.F. is more stable to pH when bound to cyanocobalamin than when 
not.
The mode of action of I.F. in vivo would require that it be 
capable of functioning over a range of pH values. It is produced 
into an acid environment which facilitates the release of B^^ ftom 
foodstuffs allowing the I.F. to become complexed with it whence it 
passes into a neutral environment in the intestines where it has 
its maximum binding capacity. This increase in B^^ binding 
capacity on moving from acid to neutral environment is demonstrated 
in Table 8 .
These results show that over the short term the pH inactivation 
of I.F. is not caused by dénaturation but merely that the extreme
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acid pH environment is not conducive to binding. This suggests 
that the amino acids at the B^^ binding site have an optimum pH 
which is slightly basic. The reduction in cyanocobalamin binding 
ability caused by extremely basic pH tended to be of a more permanent 
nature, probably because the I.F. molecule has not evolved to exist 
in a very basic environment.
These results are in accordance with those found by Goldberg 
et al (51) and Shum et al (62) except no evidence was found for the 
increase in B^^ binding ability found below pH 3 by the latter 
group for hog I.F. This group used commercial hog I.F. which 
probably contained at least 65% non-I.F. This increase in binding 
below pH 3 was probably due to this non-I.F. component.
The experiment, examining the turnover of cyanocobalamin on 
I.F. showed that in the presence of excess free cyanocobalamin, the 
equilibrium level of exchange between the initially bound and 
initially free cyanocobalamin was over 80% achieved after 8 hours. 
Extrapolation of the initial turnover cyanocobalamin when a 9-fold 
excess of free cyanocobalamin was present showed 100% turnover of 
cyanocobalamin in less than 2 hours.
These rates appear to be about double that found by Donaldson 
and Katz (63) but again this is probably due to the fact that they 
used gastric juice as the source of I.F.
This result highlights the importance of fasting before and 
after a Schilling Test or Whole Body cyanocobalamin retention test.
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A table of vitamin B-„ content in foodstuffs shown by Chanarin (64)iZ
suggest that 10 B^ ^^  could easily be ingested.
This amount could exchange with at least 50% of the labelled 
cyanocobalamin on the I.F. before absorption, giving a falsely low 
result.
The comparison of the results of the amino acid analysis with 
those of Allen et al (18) shows that the protein isolated was 
most likely the same.
The difference in the carbohydrate composition is difficult 
to explain except in terms of the differences between the two 
methods of isolation, i.e. temperature and molarity of guanidine-HCl 
used.
It is disappointing that these results were not closer, because 
it is probable that the different properties of I.F. found by 
different groups of workers cannot be resolved until a universally 
accepted method of preparation of pure I.F. is established.
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CHAPTER IV
IMMUNOLOGICAL PROPERTIES OF HUMAN AND HOG I.F. AND HUMAN AND HOG
I.F.-CYANOCOBALAMIN COMPLEX
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INTRODUCTION
In order to find if there were any immunologically 
recognisable differences between the structure of pure human 
I.F. and pure hog I.F., antibodies to each were raised in rabbits.
It was hoped to raise pure Type I or blocking antibodies to pure 
human I.F. and pure hog. I.F. and examine the cross specificity 
between them to the heterologous I.F. and also to heterologous 
and autologous pure I.F.-cyanocobalamin complex.
Impure commercial hog I.F. preparations have long been used 
orally in the treatment of pernicious anaemia. It is known that 
patients undergoing long term treatment with hog I.F. develop a 
refractoriness to it (65) and that this state is accompanied by 
the appearance of antibodies specific to hog I.F. in the patient's 
serum. These antibodies do not block the binding of to I.F. 
(66) nor do they affect the absorption of B^^ administered orally 
with human I.F. Therefore, it seems likely that antigenic 
determinants of such antibodies are not on the B^^ binding site of 
the hog I.F. molecule and that these antibodies are species specific 
Such antibodies have been called Type II or binding antibodies and 
are in contrast to Type I antibodies which were thought not to be 
species specific (67), although some workers could not demonstrate 
this cross specificity, (68, 69). This was probably due to the 
high proportion of non-I.F, B^^ binders contaminating the hog I.F. 
preparations used, which could be as high as 90% (70) .
- 116 -
It was also hoped to use these pure antibodies in the "in 
vitro" assay for I.F. described in Chapter II instead of serum 
from pernicious anaemia patients. Furthermore, it was hoped 
that such an antibody might be used to develop a more specific 
immunoassay for I.F. (see Chapter V).
A specific antibody for I.F. could perhaps be used to trace 
more accurately the metabolism of I.F. in mammals. Some 
preliminary work was carried out with the antibody produced to 
pure human I.F, by Dr, I. Brown in the Department of Pathology, 
Western Infirmary, Glasgow, using a peroxidase staining technique
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SECTION I
IMt^K^SATTON__OF__RAbBITS
Intrinsic factor preparations, isolated as described above, 
were used to immunise New Zealand White female rabbits. Blood 
was taken from the rabbits before immunisation commenced, allowed 
to clot overnight at 4®C, spun at 5,000g for 15 minutes and the 
serum removed and stored at -20°C in 1 ml aliquots for use as 
controls in later immunoprécipitation experiments. Three rabbits 
received Human I.F. and four received Hog I.F. Each dose 
contained approximately 75 pg I.F, as measured by Vitamin B^2 
binding activity, in aqueous solution in a 2 ml emulsion with Freunds 
adjuvant in a 1 : 1 ratio. The components were emulsified by 
repeated passage through a fine guage syringe needle. The dose 
was administered by one x 0.5 ml intramuscular injection into each 
hind quarter and several approximately 0.1 ml subcutaneous injections 
into the rabbit's sides, back and neck. The initial two doses were 
mixed with Freund's incomplete adjuvant and subsequent doses 
repeated at 14 day intervals, with Freund's complete adjuvant.
Blood was collected by nicking a marginal ear vein after the fourth 
dose and tested for antibody activity. After the titre of antibody 
had risen to a reasonable level, the time between booster doses of 
antigen was lengthened and the amount of antigen reduced to 
approximately 30 ^g/dose.
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DETECTION OF__ANTIBODIES IN RABBIT _SERUM
The initial test for presence of antibody in Rabbit Serum 
was to utilize a modification of the procedure used to measure 
I.F. activity "in vitro" described in Chapter II, in which the 
I.F. preparation used as antigen was substituted for the test 
material and the rabbit serum as source of antibody. The uptake 
of B^2 by the rabbit antibody serum (Tubes 2) was more important 
in this test since the B^^ binding capacity of rabbit serum was 
much higher than human serum, and thus would cause an erroneous 
result if not taken into consideration. If this test proved 
positive for a given rabbit, further quantification and charact­
erisation of the antibody was carried out.
QUANTIFICATION OF I.F. ANTIBODY IN RABBIT SERUM
In order to assay the titre of I.F. antibody present in a 
given sample of rabbit serum, a modification of the method of 
Ardeman § Chanarin (71) was used.
Two sets of duplicate glass test tubes were set up and 
labelled. One set received 50 ^1 each of normal rabbit serum 
and the other set received 50 pi each of rabbit serum containing
I.F. antibody. Then increasing amounts of the I.F. preparations, 
which were used as antigen to raise the particular antibody being 
assayed, were serially added to both sets of test tubes. The
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I.F. preparation had previously been diluted to contain 40 ng 
cyanocobalamin binding capacity per ml, and the amounts added to 
the tubes were 50, 100, 200, 250, 300, 350, 450 pi etc. respectively, 
Normally 600 pi (24 ng cyanocobalamin binding capacity) was enough 
to use up all the antibody in a given 50 pi sample of serum. The 
volumes in all the tubes were equalised with O.IM phosphate buffer 
pH 7.5.
After 5 minutes incubation at room temperature with occasional 
57shaking, 30 ng [ Co] cyanocobalamin, containing approximately
10,000 c.p.m. was added to each tube in a volume of 0,5 ml.
The tubes were incubated for a further 10 minutes, then the 
57
free [ Co] cyanocobalamin was separated using albumin coated
charcoal and centrifugation as described previously. One ml
aliquots of the clear supernatant were counted for protein bound 
57[ Co] activity and by calculation the amount of I.F. binding to 
each tube was found and expressed in ng units.
RESULTS
The titre of antibody found after two months of immunisation 
as described above, in the serum of a rabbit innoculated with pure 
hog I.F. is shown in Graph 9,
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57GRAPH 9 - Amount of [ Co] cyanocobalamin bound by increasing amounts 
of hog I.F. in the presence of either 50 ul normal 
rabbit serum or 50jil rabbit serum containing antibody 
to hog I.F.
From Graph 9 it can be seen that in the absence of I.F. the 
50 pi of rabbit serum could still bind 1.7 ng of cyanocobalamin.
Therefore, this serum has a cyanocobalamin binding capacity of 
34 ng/ml.
The hog I.F. used was previously diluted to contain 40 ng 
cyanocobalamin binding capacity per ml. It is, therefore, not 
surprising that when incubated with the fixed amount of normal 
rabbit serum the I.F. bound cyanocobalamin found in the supernatant
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after treatment with albumin coated charcoal increased by 
approximately 2 ng with every 50 pi increase in the amount of hog
I.F. added.
With the serum containing the antibody, the amount of I.F.
57bound [ Co] cyanocobalamin did not start to increase until 
270 pi of I.F, preparation had been added. This corresponds to 
the blocking of 10.8 ng cyanocobalamin binding by the hog I.F. by 
50 pi serum.
Therefore, the titre of the antibody could be expressed as 
216 units of antibody per ml, since 1 ml of serum would block the 
binding sites of an amount of hog I.F. which would have bound 
216 ng of cyanocobalamin in the absence of the antibody.
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SECTION 2
CHARACTERISATION 0F_ INTRINSIC_ FAÇTOR__ANTIBODIES
Ouchterlony Plates were prepared as follows:-
Agar containing 1.7% w/v ’’Oxoid" purified agar and 0.1% w/v 
sodium azide in 0.9% w/v saline was melted in an oven at 120°C, 
Twenty ml of this agar was pipetted into each disposable petri 
dish used and allowed to set at room temperature. After setting 
wells were cut in the agar using cork borers at a distance of 
approximately 12mm (6mm diameter for antigen well and 10mm for serum 
well). The agar plugs were removed with a pasteur pipette using 
suction. Various patterns were used for the wells, depending on 
the antibody/antigen reaction being studied. The plates were kept 
at room temperature after the wells had been filled and were 
observed every 24 hours for signs of precipitation. If the titre 
of any sample under test was low, its well was refilled after the 
first aliquot had diffused into the agar.
RESULTS
After several days incubation, single precipitation lines 
appeared between the rabbit anti-human I.F. serum and both pure 
human I.F. and pure hog I.F., also a faint accompanying line
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appeared between this antibody and the human I,F.-cyanocobalamin 
complex.
Single precipitation lines appeared between the rabbit 
anti-hog I.F. antibody and both the pure hog I.F. and pure human 
I.F. but no lines appeared between this antibody and either the 
hog I.F.-cyanocobalamin complex or the human I.F.-cyanocobalamin
complex.
This suggested that there was cross specificity between the 
human and hog Type I antibodies raised to the pure I.F. preparations
It also suggested that the rabbit anti-human I.F. antibody 
serum might contain more than one antibody.
Either of the antibody sera 'was capable of blocking the I.F. 
mediated binding capacity of normal human gastric juice on 
commercial hog I.F. preparations, but good precipitin lines could 
not be shown with either of . these antigens, probably due to the 
low I.F. concentration.
Rë6ÇTI0N^Cf_EXPhBTMENT^hI^_PR0DUCED_ANTIGEN_T0_HETER0L0G0US 
AND_AUTOLOGOUS I.F. _ M D _ I .F^ ^  _I^LgOLUTION
In order to explore further the cross reactions of the antibody 
raised to pure human I.F. and the one raised to pure hog I.F., it
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was necessary to set up a series of test tubes containing all the
possible combinations and permutations of the materials available.
These were rabbit antiserum against human I.F. , antiserum
against hog I.F,, pure human I,F, and pure hog I.F., both of
57
which could be complexed with either unlabelled or [ Co] labelled
cyanocobalamin and pure human I.F. and pure hog I.F. labelled 
1 75
with [ I] (protocol, Ch.5).
Briefly, 0,1 ml of either antiserum, diluted to contain 5 ng 
units of antibody, was preincubated for 30 minutes at room 
temperature with a 50-fold excess of either the heterologous or 
autologous I .F. or I.F.-unlabelled cyanocobalamin complexed in 
a volume of 1 ml in O.IM phosphate buffer pH 7.5 in duplicate 
conical glass test tubes. Control tubes were also set up which 
contained 0.1 ml of normal rabbit serum, collected before 
immunisation commenced. Then to each tube was added 0.1 ml,
5 ng units of heterologous or autologous I.F. labelled either
57 125
by having complexed to [ Co] cyanocobalamin or with [ I] .
The permutations and combinations used are shown in Figs. 3,
4 and 5.
After a further 30 minutes incubation at room temperature 
with occasional shaking, 0.1 ml of a 1 in 40 dilution in saline 
of donkey anti-rabbit precipitating serum (Wellcome Reagents Ltd.) 
was added to each tube, shaken, and left overnight at 4°C.
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FIGURE 4 HUMAN I.F. ANTIBODY
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FIGURE 5 HOG I.F. ANTIBODY
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The tubes were then centrifuged at 10,000g for 15 minutes.
The supernatants were sucked off with a pasteur pipette and
discarded. The tubes were allowed to drain upside down onto
paper towels for 15 minutes then the pellets were counted in the
well-type gamma-radiation counter. The KeV and E.H.T. settings
of the J § P Engineering counter/rate meter were adjusted for
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maximum efficiency on [ Co] or [ I] standards as required.
RESULTS
The results shown in Table 9 are the average of the duplicate 
tubes over two runs of the experiment. The numbers refer to the 
numbers of the tubes shown in Figs. 3, 4 and 5.
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TABLE 11 - The percentage added I.F. activity [ Ço]_or_[ _ I]
precipitated out by the donkey anti-rabbit precipitating 
serum after preincubation of the antibody with excess 
heterologous or autologous I.F, or I.F.-B^^ complex.
PERCENTAGE ACTIVITY IN PELLET 
57
(Tubes .1-8 are [ Co] activity:
125
tubes 9-16 are [ ] activity)
TUBE Rabbit Rabbit
serum antibody serum antibody
No. Normal Rabbit against against
Serum Control human I.F. hog I.F.
(Fig. 3) (Fig. 4) (Fig. 5)
1 4.2 6.2 2.7
2 3.7 3.7 5.2
3 4.1 29.8 3.6
4 2.7 32.4 2.8
5 3.5 2.4 4.4
6 4.2 4.7 7.2
7 4.1 6.3 5.4
8 7.2 3.7 6.1
9 1.9 2.5 8.2
10 3.6 76.7 78.2
11 4.3 7.5 3.9
12 8.7 69.8 81.3
13 4.4 3.4 6.7
14 3.2 63.2 72.2
.15. 3.1 5.9 4.9
16 2.5 67.4 74.3
As might be expected, the pellets from tubes detailed in Fig.3 
all contained less than 10% of the added I.F, activity since there 
was no specific antibody in the control serum to bind with any of
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the pure I.F. preparations.
In the pellets from the tubes detailed in Fig. 4 which 
contained the antibody serum raised to pure human I.F. about 30% 
of the added activity was found in Tubes 3 and 4. This suggested 
that there was an antibody to Human I.F.-8^2 complex present.
Few counts appeared in pellet 2 which backed up this proposal, 
since the excess of human I,F .-unlabelled B^2 present would use 
up such an antibody. Furthermore, few counts appeared in pellets 
from Tubes 5, 7 and 8 which might suggest that this antibody is 
species specific.
125
In the human I.F. antibody tubes to which [ I] labelled
I.F. not complexed to cyanocobalamin was added, about 70% of the
activity appeared in Tubes 10 and 12. This suggested that the
rabbit antiserum to human I.F. contained a second antibody which
was not blocked by I.F.-cyanocobalamin complex. This antibody
was not species specific since it bound to both human and hog 
125
[ I] I.F. as shown by the approximately 60% binding in Tubes
14 and 16. This percentage was slightly lower than Tubes 10 and
12 which was probably due to the rabbit anti-human I.F. Type II
125
antibody not binding to the hog [ I] labelled I.F.
The I.F. antibody appears from these results to be present 
in approximately double the concentration of the I.F.-B^2 complex 
antibody. The appearance of two antibodies could have been
- 128 -
caused by a minute amount of human complex contamination
in the human I.F. preparation used to immunise the rabbits.
The pellets from the tubes detailed in Fig. 5 only contained 
a high percentage of added activity in Tubes 10, 12, 1.4 and 16 
which suggests that only one antibody was present.
This antibody raised against pure hog I.F, does not appear
to be species specific since it binds to both human and hog 
125
[ I] labelled I.F. but it was not blocked by either of the
I.F.-cyanocobalamin complexes.
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SECTION 3
The Use of therabbit anti-pure human^I.F._antibody^conjugated_to 
peroxidase for staining of sections of human stomach.
The rabbit anti-human I.F. antibody was used in a modification 
of the technique described by Petts and Roit [72] to stain sections 
of human stomach.
1. First, fixed sections were washed with 0.5% hydrogen peroxide 
in methanol to block the endogenous peroxidase activity e.g. 
from red blood cells, eosinophils.
2. The collegen tended to be stained, but this was toned down by 
preincubating the section with swine normal serum diluted
1 in 5 in Tris-saline.
3. The section was then washed and incubated with the rabbit 
anti-human I.F. antibody diluted 1 in 250 with the tris-saline
4. The section was again washed and swine anti-rabbit protein 
antibody added.
5. The excess swine anti-rabbit protein antibody was removed and 
Peroxidase conjugated to rabbit anti-peroxidase antibody 
applied to the section. This antibody was bound to the
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rabbit-anti-human I.F. antibody by the swine anti-rabbit 
protein antibody.
6 . Finally, the section was washed and 3, 3 ’ diaminobenzidine
tetrahydrochloride was applied, giving rise to the colour
reaction.
The principle of this colour reaction is : - 
The electron donor is oxidised at the very site of action of 
the enzyme, (peroxidase, linked to the rabbit anti-human I.F. 
antibody) and not at a distance from it.
Diaminobenxidine, when donating electrons to the hydrogen
peroxide via the peroxidase, apparently forms an oxidative 
intermediate (see Fig. 6) that rapidly polmerises to an amorphous 
insoluble brown deposit which can easily be seen under light 
microscopy.
Controls were set up using normal rabbit serum instead of 
the rabbit anti-human I.F, serum, and they showed no specific-, 
staining of any cells.
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NH.
oxidative polymerisation
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Oxidative cyclation
FIGURE 6 - Polymerisation of the diaminobenzidine to form the
insoluble brown deposit visible under light microscopy
RESULTS
This technique has proved to be very effective in the 
preliminary work done so far. The examples shown in 
Illustrations 1 and 2 are comparisons of sections of stomach 
mucosa under 100-fold magnification stained (Illus. I) using a 
conventional periodic acid Schiff-toluidine blue-tartrazine 
method, and (Illus. 2) using the antibody linked peroxidase 
reaction using the diaminobenzidine stain.
The parietal cells, which are the site of production of 
I.F. are much more clearly defined in Illustration 2.
Illustrations 3 and 4 show a higher magnification (x 500) 
comparison of the two techniques.
The black staining with the immunoperoxidase reaction in 
Illustration 4 shows the presence of intrinsic factor within the 
parietal cells.
On some sections of stomach from patients with gastritis, 
where the mucosa had become atrophied and under conventional 
staining had the appearance more of intestinal mucosa, the I.F. 
antibody linked peroxidase showed up the parietal cells and made 
the identification of the sections much easier.
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ILLUSTRATION I
Gastric mucosa
Specimen from patient with 
duodenal ulcer showing 
parietal cell hyperplasia. 
Section is stained with 
periodic acid Schiff- 
Toluidine Blue-Tartrazine 
in which the parietal cells 
stain yellow with the 
Tartrazine, and are the 
light grey cells in the 
photomicrograph, (x 100)
ILLUSTRATION 2
Gastric mucosa
treated with Rabbit 
Anti-human I.F. antibody, 
the immunological reaction 
being visualised by the 
Immuno-peroxidase technique 
(Peroxidase-antiperoxidase 
reaction) and stained with 
the diaminobenzidine (DAB) 
reaction. A positive 
reaction is indicated by an 
intense black colouration of 
the cells. The positive cells 
are all histologically 
parietal cells.
(PAP-DAB, Mayers Haematoxylon 
Countmrstain x 100)
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ILLUSTRATION 3
9
&
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I
Gastric Mucosa -
Higher magnification 
of Gastric Tubular Glands 
showing typical parietal 
cells among peptic cells.
(PAS-TB-TART x 500
ILLUSTRATION 4
Gastric mucosa- 
Higher magnification of 
gastric glands showing 
cells with the charact­
eristics of parietal 
cells staining black with the 
immuno-peroxidase reaction, 
indicating the presence of 
intrinsic factor within the 
cells.
(PAP-DAB, Mayers Haematoxylin 
Counterstain X 500
An interesting development was that.when the I.F. antibody- 
peroxidase staining technique was carried out on sections from 
liver and kidney tumours, some of the tumours had cells which 
appeared darkly stained, perhaps suggesting that the primary 
tumour came from the stomach.
DISCUSSION
None of the rabbits which were immunised with either of the 
I.F. preparations failed to produce any antibodies although the 
titres varied. Thus, the I.F. preparation was very antigenic.
The results of both the Ouchterlony plates and the reaction 
of the antibody and antigen in the presence of excess heterologous 
and autologous I.F. suggest that in fact, two antibodies corresponding 
to Type I and Type II antibodies appeared in the rabbits immunised 
with the human I.F. preparation. This was probably due to the 
presence of some cyanocobalamin in the human I.F. preparation, 
which was not intentional, but in fact, provided a more interesting 
result, since unlike the Type I antibodies, this antibody showed 
a marked species specificity and could not be blocked by pure hog 
I.F.“Cyanocobalamin complex or pure hog I.F. This antibody was 
blocked by pure human I.F. not complexed to cyanocobalamin, therefore, 
the cyanocobalamin was not one of its antigenic determinants.
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The fact that neither the human nor the hog anti-human I.F.
Type I antibody was blocked by excess of either autologous or 
heterologous I.F.-cyanocobalamin complex, suggests that.their 
antigenic determinants are on or near the cyanocobalamin binding 
site of the I.F. molecule. This binding site portion of the molecule 
must be very similar for both sepcies hence the cross specificity of 
the Type I antibody.
However, the molecules are not immunologically identical, 
since the Type II antibody, which has determinants remote from the 
cyanocobalamin binding site is species specific. These findings 
are in agreement with those of Gullberg (73, 74, 75).
One of the persisting uncertainties in metabolism is 
whether the is carried into the ileal enterocyte still bound 
to I.F. or whether the delay found in the appearance of B^^ i# 
portal blood (76) is caused by the time taken to be split from I.F.
It being well known that B^^ is not absorbed in the absence of I.F. 
(except if given in vast excess), is the role of I.F, merely to 
transport the B^^ through the intestine and bind it to specific 
receptor sites, after which its role is ended? There is much 
evidence that this is certainly the initial role of I.F. using 
tissue homogenates (77) and everted sacs of animal intestines (78,79) 
etc., but :.it has not yet been resolved definitely if its role ends 
there.
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In 1964, Herbert et al (80) suggested that split from
I.F. during absorption but did not present any evidence to support 
this. Cooper § Castle (81) claimed to have found an I.F. releasing 
factor in homogenates of small bowel, but it has now almost certainly 
been shown that this releasing factor was free B^^ itself, interchanging 
with the I.F. bound
More recently Katz and Cooper (82) isolated a soluble receptor 
from human intestine, but they have not shown whether this receptor 
mediates the absorption of I.F.-B^g or only B^2 *
The fact that patients treated with oral hog I.F. develop 
antibodies towards hog I.F. seems to suggest that I.F. is absorbed 
along with the B^2 ‘ The refractoriness to treatment with oral hog 
I.F. associated with these antibodies is not evident when human I.F. 
is given orally. It is possible that only part of the I.F. molecule
is absorbed, but most likely part to be absorbed would be the 8^2
binding site area. The Type I I.F. antibodies raised in the present 
study displayed no species specificity but the antibody found in 
patients treated with hog I.F. does not affect the absorbance of
B^2 when it was given orally with human I.F.
Therefore, this antibody does show species specificity as did 
the Type II antibody which was raised in the present study and whose 
antigenic determinants were remote from the B^2 binding site..
Therefore, it seems likely that at least most of the I.F. 
molecule is absorbed.
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Recent work by Rothenberg et al (83) using differential
centrifugation on guinea- pig ileal homogenates, the animals being 
57
killed after [ Co] labelled human I.F. had been incubated in their 
ileal loops, found a large percentage of the radioactivity was 
localised in the mitochondial fraction. This finding had been 
made before (84) but the more important result was that 57% to 78% 
of this activity could not be removed by coated charcoal and that 
54% to 69% of the activity could be precipitated along with anti-human 
I.F. at 15% Sodium Sulphate concentration indicating that a high 
percentage of the inside the enterocyte is localised at the 
mitochondrial membrane and is bound to a large molecule with the 
immunological identity of I.F.
The work of Peters § Hoffbrand (84) again using differential 
centrifugation, supports that is localised in the mitochondial 
fraction during absorption, and in fact present results showing 
that a high proportion of the B^^ is associated with the inner 
rather than the outer mitochondial membrane although they have 
no firm explanation for this.
Perhaps the enterocyte mitochondia are the site for the exchange 
of B^2 f^om I.F. to its transcobalamin to which recently absorbed 
B^2 i^ attached in portal blood, (85) . If so, what then is the 
eventual fate of I.F.?
The evidence presented by Ardeman et al (86) that I.F. is not 
absorbed, is based mainly on the observations that patients with
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pernicious, anaemia who have serum antibodies to I.F. still absorb 
orally administered bound to I.F., but the results presented 
here show that the activity of the Type I antibody was not blocked 
by I.F.-B^2 complex, since the antigenic determinants are probably 
on or near the B^2 binding site of the I.F. molecule. Therefore, 
I.F.-B^2 absorption would not be affected by these antibodies.
These results obtained by Rothenberg (83) seem to be close to 
finding a solution to the question, but this work was still carried 
out using human gastric juice as the source of I.F.
The work could be repeated and expanded using the pure I.F. 
preparations and pure antibodies made possible by the use of affinity 
chromatography. Also with a pure I.F. preparation, it is possible 
to attach a label directly to the protein (See Chapter V), in order 
that the fate of the I.F. molecule after it has split from B^2 
could be followed.
Further the pure I.F. antibody linked peroxidase staining 
technique offers much scope for further localisation of I.F. sites 
of action. At the sub-cellular level it could be used at much 
higher magnification (electron microscopy) on sections from the 
pellets formed with differential centrifugation on tissue homogenates',
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CHAPTER V
RADI9ACTIVE__LAbELLJNG__OF__HHMAN__AND_JHOG__T^TRINSIC__FAÇpOR 
USING l^^IODINE
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Until recently, the most common way of tracing the whereabouts
of I.F., or for that matter, any B^^'binding protein, was to form a
57complex with radioactive [ Co]. Much insight and information about 
I.F. metabolism has been gained • using this technique, but it has 
a severe limitation.
The binding between I.F. and is a chemical reaction which
has an equilibrium constant, which can be affected by the concentrations 
of either component.
I.F. + B^2 —------- I,F,~B^2 complex
Therefore, in the presence of free unlabelled B^2 , the labelled
B^2 will effectively be diluted off the I.F. present. This means
57
there is always an element of doubt about whether the I.F.-[ Co]B^2
57
complex is being monitored or free [ Co]B^2 '
Similarly, with the mechanism of B^2 absorption, it is difficult 
to trace the fate of the I.F., since the complex may be split at the 
brush border of the distal ileum.
For these reasons, and also with a view to developing a more 
rigid "in vitro" assay for I.F., it was decided to try to incorporate 
a radioactive label directly into the pure I.F. preparation isolated 
in the present work.
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SECTION I
1
PRODUCTION OF [ I ]  LABELLED I.F
METHOD
The only isotope studied for the purpose of labelling I.F.
125was [ I]. The method employed was a modification of that of 
Greenwood et al (87) as described-- by Mackenzie et al (88) .
These workers estimated the quantity of Chloramine T which 
would have the least destructive effect on the [^^Co] binding 
activity of I.F. They used human I.F. purified by the method of 
Chosy § Schilling (32).
For the present study, a range of chloramine T concentrations, 
suggested by Mackenzies results, were tried to give maximum 
incorporation of label.
!
The best yields were found using the following protocol -
50 pg of either the human or hog I.F. preparation in 0.5 ml
O.IM phosphate buffer pH 7.5 was placed in a conical plastic
125
disposable tube behind a 10 cm thick lead shield. 0.5 mCi Na I 
(Radiochemical Centre, Amersham) in a volume of 10 pi was added using 
an automatic pipette with a disposable tip. Then 30 pg Chloramine T 
(B.D.H.) was added in a volume of 15 pi and the plastic tube was
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vortex mixed and allowed to incubate at room temperature for 10 minutes 
with occasional shaking.
The reaction was stopped by the addition of 120 pg sodium
metabisulphite in a volume of 100 pi. The tube was vortex mixed
again, and the contents applied to the top of a 10 cm x 0.5 cm
125
Sephadex G-10 column to separate the free from bound [ I], except 
for a 10 pi sample which was subjected to high voltage paper 
electrophoresis to find % incorporation of the label. This 
electrophoresis was carried out on 24 cm x 2 cm Whatmann No.l 
paper strips, using 0.05M barbitone buffer pH 8.6 at a voltage of 
500v for 50 minutes at room temperature.
The column was eluted with O.IM phosphate buffer and 1 ml
125
aliquots of the eluant were collected and counted for [ I] activity,
125
The fractions containing the protein bound [ I] were pooled, 
and another sample was subjected to high voltage electrophoresis to 
check the effectiveness of the column separation.
The paper strips were previously marked in 1 cm lengths from 
the origin at the Cathode.
When the electrophoresis was complete, the strips were dried.in 
a drying cupboard at 37°C overnight, then cut into 1 cm long segments 
and each segment counted for activity.
141 -
RESULTS
125
SE PARATION _0F _ FRE E _ F ROM _ BOUND
The 1 ml aliquots which were collected from the G-10 column 
125were counted for [ I] activity and the results are plotted in 
Graph 10).
40
- Protein bound
12530
o  20 125
2 4 6 8 10 12 14\ 16 18 20 22 24
Elution Volume (ml)
125
GRAPH 10 - Elution pattern of [ I] labelled_hog I.F. reaction
mixture from Sephadex G-10 column
Graph 10 shows the elution pattern found when 50 fig pure hog
125
I.F. was subjected to the [ I] labelling process. The protein 
125
bound [ I] was excluded from the column and appeared in a peak
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between volume 3 ml and 6 ml. The free iodine did not appear until 
19 ml had flowed through the column.
EFFICIENCY OF INCORPORATION
To find the percentage incorporation of the label in the protein,
a 10 jal sample from the above reaction mixture was subjected to
paper electrophoresis. After the paper strips had been run, dried
125
and cut into 1 cm lengths, each segment was counted for [ I] activity,
The results are shown in Graph 11.
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40
Origin
30
125Free
20
o
Protein
bound
»i   .1.1.1   . i ...
10 12 14 16 18 20 224 6-2 2 80
Distance from origin (cm)
1 ?5
GRAPH 11 - Electrophoretic Distribution of [ I] activity of 10 ul
labelling reaction mixture' run in 0.05M barbitone buffer 
at SOOv for 50 minutes.
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125
As can be seen from Graph 11, the protein bound [ I] had
125
remained close to the origin whereas the free [ I] has migrated 
12 cm towards the anode.
By adding of all the counts found in the protein peak and
dividing by the total no. of counts, it was found that 43% of the 
125[ I] label had been incorporated in the I.F.
125
PURITY OF [ I ] - I . F .  PRODUCT
A 10 jjil sample was taken from the pool of the fractions from
125
the G-10 column containing the [ I] I.F. This was also subjected 
to high voltage paper electrophoresis as described above and the 
results are shown in Graph 12,
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GRAPH 12 - Efficiency of separation of_free from bound [ I]_on
Sephadex G-10 column
From addition of all the counts found in the protein peak in
125
Graph 12, it was found that the [ I] eluted with the I.F. from 
the G-10 column was 97% bound.
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SECTION 2.
IOC:
PROPERTIES OF [ I ]  LABELLED I.F.
It was necessary to check that the identity of the pure I.F.
125
preparation had not been altered by the [ I] labelling process.
Some of the results for this have already appeared in previous 
Chapters.
125
The [ I] I.F. was subjected to gel filtration on a Sephadex
125
G-200 column as described in Chapter.* Ill. The [ I] activity
was eluted in a single peak associated with a protein with a
57
molecular weight very similar to I.F.-[ Co] cyanocobalamin complex.
125
The Bj2 binding activity of the [ I] I.F, complex was tested
by the "in vitro" I.F. assay described in Chapter II. This
125
procedure was complicated slightly by the overflow of the [ I]
57activity into the [ Co] energy band. This problem was eliminated
57
by increasing the specific activity of the [ Co] cyanocobalamin 
used and by introducing a 1 mm thick sheet of aluminium between the
crystal of the counter and the sample. The aluminium screened out
125 57
the [ I] emissions but allowed the [ Co] activity through to the
crystal.
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It was found that approximately 85% of the binding activity 
of the I.F. was retained after the iodination.
125 57A sample of [ I] I.F.-[ Co] cyanocobalamin was also applied 
to the Sephadex G-200 column and the two activity peaks coincided 
in the elution pattern.
125
In Chapter IV, the [ I] I.F. was used to examine the cross­
specificity of the human and hog I.F. antibodies. This experiment
125also showed that the [ I] I.F. retains the immunological identity 
of I.F.
125
Thus the [ I] I.F. was judged not to have been significantly 
altered by the process of iodination, using the method described, 
although an "in vivo" absorption test was not carried out with it 
because 6f its high activity (approximately 50 |iCi/ug).
The rate of inactivation of the I.F. caused by the activity of
1 o c
the [ I] was fairly high. On storage at -20°C about 50% of the 
B^2 binding capacity of the I.F. was lost after 14 days, and at 
room temperature 50% binding was lost after four days. Lower 
activity samples could be made to reduce this inactivation.
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SECTION 3
RADIOIMMUNOASSAY FOR INTRINSIC_^FACTOR
With an isotope labelled species of intrinsic factor and a 
pure antibody to it, it seemed logical to try to use these in an 
assay system for I.F. This assay would be specific for I.F. and 
would not recognise non-I.F. protein or even I.F. bound to 
Thus it could be used to probe tissue homogenates, portal blood etc, 
for the existance of absorbed I.F. molecules, perhaps after the 
transfer of the ftom I.F. to the transcobalamins, if this happens 
within the cell.
There was not time to try the above experiment, but a preliminary 
assay was developed which appeared to work satisfactorily .
The rabbit anti-hog I.F. antibody was used as the fixed binder.
It was diluted in normal saline to contain 5 ng units of antibody per 
ml.
125
A series of test tubes were set up and 5 ng units of [ I] I.F. 
in a volume of 0.25 ml was added to each (approximately 0.2 pg).
A serial dilution of unlabelled hog I.F. was prepared containing
0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5 and 5 pg I.F. each and 0.25 ml 
from each was added to the appropriate test tube and mixed. Then
0.5 ml of the antibody preparation was added to each tube, mixed and
148
incubated at room temperature for 10 minutes. After this time
0.1 ml of Donkey anti-rabbit precipitating protein, (Wellcome Labs.) 
1 in 50 dilution in saline, was added plus 0,2 ml of normal rabbit 
serum. This rabbit serum was merely to increase the size of the 
final pellet.
The tubes were incubated at 4‘*C overnight and then centrifuged 
at 10,000g for 15 minutes.
The supernatants were removed by pasteur pipette and discarded
-125
and the pellets were counted for [' I] activity.
The results are shown in Graph 13. The activity found in the 
pellet was subtracted from the total activity added to find the 
% Free and % Bound activity. The activity in the pellet was then 
expressed as a ^^®®/Bound ratio.
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GRAPH 13 Standard Curve for radioimmunoassay of I.F.
the work done on this is of a very preliminary nature, although 
the results seem to indicate that a very sensitive assay for I.F. 
could be developed.
This assay could be speeded up by using ammonium sulphate 
precipitation to separate the free and antibody bound I.F. instead 
of anti-rabbit precipitating serum, but this was not explored.
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DISCUSSION
Radioactive iodine was the only isotope label investigated but
it is not the ideal label for I.F. One reason for this is that
125
if the I.F. molecule broke up and released the iodine, when [ I] 
I.F, was being used to test for I.F. absorption in the intestine, 
the free iodine would be absorbed, thus giving inconclusive results.
125 57
Further [ I]I.F.-[ Co] cyanocobalamin complex is not useful
125
for whole body monitor studies, because the [ I] emission is too 
weak to be effectively measured at a particular location in the body
51
More useful results could be obtained using Chromium label 
but this isotope was not available at the time. The actual 
incorporation of [^^Cr] should be no more difficult than [^^^I] .
51The [ Cr] could be more easily traced using a Whole Body 
Monitor and also would not be absorbed if released from the I.F.
Yamaguchi et al (89) used [^^Cr] to label I.F. in 1970 to 
measure the intestinal absorption of I.F. They found only trace 
amounts of the label absorbed.
They used a stepwise column chromatography technique to isolate 
human I.F. from 200 ml of gastric juice. This must have yielded a
very small quantity of pure I.F. indeed. They also used a
commercial hog I.F. preparation which probably contained a high 
proportion of non-I.F. B^2~binders.
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Many of the "in vitro" properties of pure I.F. could be studied
12
125using [ I] incorporation as opposed to relying on labelled B
which is only transiently bound to I.F.
The conditions used for the iodination were the mildest possible
consistent with a reasonable level of incorporation of label. The
activity of the Iodine used was probably too high since it caused
fairly rapid destruction of the I.F. binding capacity at room
temperature, but this could easily be lowered. The experiments 
125with the [ I] labelled I.F. suggested that the molecular structure
had not been affected by the iodination process. Free iodine was
125
not released from the fresh [ I] I.F. preparation. ^
The specific radioimmunoassay for I.F. has the potential to 
be made very sensitive and could possibly measure down to picogram 
quantities of I.F. This sensitive a tool could be very useful in 
elucidating the metabolism of I.F. mediated absorption, perhaps 
in conjunction with differential ultracentrifugation on tissue 
homogenates.
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